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  ABSTRACT	  OF	  THESIS	  	  	  INVESTIGATION	  OF	  THE	  CRITICAL	  RESIDUES	  AT	  THE	  C-­‐TERMINUS	  OF	  THE	  E.COLI	  PERIPLASMIC	  CHAPERONE,	  SURA	  	  SurA	  is	  a	  molecular	  chaperone	  in	  the	  periplasm	  of	  E.coli	  and	  has	  been	  implicated	  in	  the	  maturation	  of	  outer	  membrane	  proteins	  (OMPs).	  	  SurA	  consists	  of	  four	  domains,	  but	  only	  two	  of	  them,	  namely	  the	  N	  and	  C-­‐terminal	  domains,	  are	  necessary	  for	  chaperone	  function.	  	  Very	  little	  is	  known	  about	  which	  residues	  drive	  the	  interaction	  between	  the	  N	  and	  C-­‐termini	  that	  facilitates	  normal	  activity.	  	  We	  mutated	  several	  conserved	  residues	  on	  the	  C-­‐terminus	  and	  generated	  additive	  truncations	  to	  observe	  the	  effects	  of	  each	  on	  the	  fitness	  of	  the	  cell.	  	  We	  found	  one	  mutation	  E(408):A	  was	  sufficient	  to	  reduce	  SurA	  activity	  by	  3-­‐fold,	  but	  structural	  characterization	  of	  the	  mutated	  protein	  revealed	  little	  variation	  from	  wild-­‐type	  SurA.	  	  Most	  notable,	  we	  found	  that	  when	  at	  least	  10	  residues	  are	  removed	  from	  the	  C-­‐terminus,	  the	  protein	  is	  completely	  non-­‐functional.	  	  We	  introduced	  a	  random	  peptide	  library	  to	  substitute	  these	  10	  residues	  and	  found	  that	  ~1.5%	  of	  all	  possible	  sequences	  in	  the	  library	  can	  restore	  SurA	  function	  to	  at	  least	  50%	  activity.	  	  Moreover,	  we	  observed	  no	  pattern	  in	  the	  sequences	  of	  26	  different	  variants	  that	  were	  chosen	  and	  characterized.	  	  Here	  we	  show	  for	  the	  first	  time	  that	  SurA	  can	  tolerate	  many	  mutations	  at	  the	  C-­‐terminus	  and	  still	  be	  active.	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Chapter	  I:	  Introduction	  
1.1	  Background	  and	  Significance	  	  
Over	   the	   last	   40	   years,	   antibiotic	   resistance	   among	   infectious	   bacteria	   has	  emerged	   and	   exploded	   into	   a	  worldwide	  problem	   that	   has	   resulted	   in	   once	   easily	  curable	   infections	   becoming	   untreatable.	   	   There	   are	   many	   factors	   that	   have	  contributed	   to	   the	   spread	   of	   antibiotic	   resistance.	   	   Among	   these	   are	   the	   lack	   of	  patient	  compliance	  with	  prescribed	  directives,	  rapid	  globalization,	  and	  the	  overuse	  and	   misuse	   of	   antibiotic	   agents	   [Mitscher,	   L.	   A.,	   S.	   P.	   Pillai,	   et	   al.	   (1999)].	   	   The	  influence	   of	   humans	   has	   undoubtedly	   accelerated	   the	   natural	   genetic	   variation	  among	   bacterial	   species	   and	   has	   selected	   for	   those,	   which	   are	   less	   susceptible	   to	  antibiotics	  even	  to	  the	  point	  of	  total	  resistance	  to	  every	  approved	  drug	  [Velayati,	  A.	  A.,	   M.	   R.	   Masjedi,	   et	   al.	   (2009)].	   	   As	   a	   result,	   the	   mechanisms	   of	   bacterial	   drug	  resistance	  have	  been	  an	  active	  field	  of	  study	  in	  the	  last	  few	  decades.	  
Bacteria	   have	   four	   main	   mechanisms	   of	   defense	   against	   antimicrobials:	  exclusion	  of	  the	  drug,	  chemical	  modification	  of	  the	  drug	  upon	  entry,	  variation	  of	  the	  drug	  target,	  and	  efflux	  of	  the	  drug.	   	  Furthermore,	  bacteria	  with	  intrinsic	  resistance	  to	  a	  chemical	  agent	  can	  pass	  this	  resistance	  on	  in	  two	  ways:	  horizontal	  and	  vertical	  gene	  transfer.	  	  Vertical	  gene	  transfer	  is	  accomplished	  by	  cell	  division	  and	  horizontal	  gene	   transfer	   can	   occur	   by	   a	   number	   of	   ways	   including:	   plasmid	   conjugation,	  transformation,	  or	  transduction	  [Mitscher,	  L.	  A.,	  S.	  P.	  Pillai,	  et	  al.	  (1999)].	   	  The	  high	  frequency	   of	   genetic	   mutations	   in	   bacteria	   and	   relative	   ease	   of	   gene	   transfer	  through	  a	  rapidly	  growing	  population	  has	  the	  potential	  to	  cause	  drastic	  changes	  in	  
	  2	  
the	  viability	  of	  that	  population	  over	  a	  short	  period	  of	  time.	  	  In	  order	  to	  combat	  the	  natural	   resistance	   that	   occurs	   from	   selection	   pressures	   imposed	   by	   the	   use	   of	  antibiotics,	   there	   must	   be	   a	   continual	   pursuit	   for	   novel	   approaches	   to	   keeping	  bacterial	  infection	  under	  control.	  	  	  
No	  novel	  class	  of	  antibiotics	  was	  discovered	  between	  1962	  and	  2000.	  	  Since	  2000,	  there	  have	  only	  been	  three	  major	  classes	  of	  antibiotics	  approved	  [Fischbach,	  M.	   A.	   and	   C.	   T.	   Walsh	   (2009)].	   	   Many	   drugs	   that	   have	   been	   developed	   target	  cytoplasmic	  macromolecules,	  skirting	  around	  the	  natural	  mechanisms	  of	  resistance	  posed	  by	  bacteria.	  	  Consequently,	  many	  of	  them	  have	  been	  resisted	  by	  bacteria	  and	  rendered	   ineffective.	   	  A	  different	  approach	  might	  be	   to	   inactivate	  or	  competitively	  inhibit	  the	  mechanism	  of	  resistance,	  and	  then	  apply	  a	  conventional	  antibiotic	  to	  kill	  the	   cell.	   	  Much	   research	   has	   gone	   into	   understanding	   the	  ways	   in	  which	   bacteria	  acquire	  and	  retain	  resistance	  to	  antibiotics	  in	  hopes	  of	  developing	  ways	  to	  inactivate	  them.	   	   Of	   particular	   interest	   to	   this	   study	   is	   the	   exclusion	   mechanism,	   which	  prevents	  antibiotics	  from	  entering	  the	  cell	  at	  all.	  	  
	  
1.2	  Structure	  of	  Bacterial	  Cell	  Membrane	  
Most	  bacteria	  are	  divided	  into	  two	  categories	  based	  on	  their	  ability	  to	  retain	  or	   exclude	   the	   Gram	   stain.	   	   Those	   which	   retain	   Gram	   stain	   are	   known	   as	   Gram-­‐positive	  bacteria	  and	  those	  which	  exclude	  it	  are	  Gram-­‐negative	  bacteria.	  	  There	  exist	  distinct	  differences	  in	  the	  cell	  membrane	  structure	  of	  these	  two	  types	  of	  cells.	  	  Both	  cell	   types	   have	   a	   symmetric	   inner	   membrane	   composed	  mainly	   of	   phospholipids	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[Baron,	  S.	   (1996)].	   	  Outside	  of	   that,	  Gram-­‐positive	  cells	  have	  a	   thick	  peptidoglycan	  layer,	  with	  teichoic	  and	  lipoteichoic	  acids	  dispersed	  throughout	  the	  matrix.	  	  
	  
	  
Figure	   1.1	   Gram-­‐negative	   cell	   envelope	   (left)	   and	   Gram-­‐positive	   cell	   envelope	  (right)	  [taken	  from	  Baron,	  S.	  (1996)]	  
Gram-­‐negative	  cells	  have	  only	  a	  thin	  peptidoglycan	  layer,	  but	  are	  guarded	  by	  an	  asymmetric	  outer	  membrane,	  composed	  of	  a	  complex	  mixture	  of	  phospholipids	  and	  lipopolysaccharide	  (LPS).	  	  It	  is	  the	  extra	  outer	  membrane	  in	  gram-­‐negative	  cells	  that	  poses	  a	  significant	  barrier	  to	  the	  entry	  of	  small	  molecules.	  	  Consequently,	  when	  this	  barrier	  is	  compromised,	  the	  cell	  becomes	  more	  susceptible	  to	  antibiotics.	   	  One	  factor	   that	   can	   affect	   the	   outer	   membrane	   integrity	   is	   the	   protein	   content.	   	   Low	  outer	   membrane	   protein	   (OMP)	   content	   leads	   to	   a	   leaky	   membrane,	   allowing	  passage	   of	   small	   molecules	   normally	   excluded	   [Rouviere,	   P.	   E.	   and	   C.	   A.	   Gross	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(1996)].	   	   Many	   factors	   can	   contribute	   to	   the	   level	   of	   outer	   membrane	   protein	  content,	   thereby	   affecting	   the	   permeability	   of	   the	   cell	   to	   antibiotics.	   	   Periplasmic	  chaperones	   are	   implicated	   in	   the	   biogenesis	   and	   transport	   of	   outer	   membrane	  proteins	   [Rouviere,	  P.	  E.	  and	  C.	  A.	  Gross	   (1996),	  Lazar,	  S.	  W.	  and	  R.	  Kolter	   (1996),	  Rizzitello,	  A.	  E.,	   J.	  R.	  Harper,	  et	  al.	   (2001),	  Bos,	  M.	  P.,	  V.	  Robert,	  et	  al.	   (2007)].	   	  The	  focus	   of	   this	   study	   is	   how	   periplasmic	   molecular	   chaperone	   activity	   affects	   the	  susceptibility	  of	  E	  .coli	  cells	  to	  antibiotic	  agents.	  
	  
1.3	  Periplasmic	  Molecular	  Chaperones	  of	  E.	  coli	  	  
The	  periplasm	  is	  the	  space	  in	  Gram-­‐negative	  bacterial	  cells	  that	  separates	  the	  inner	  membrane	  from	  the	  outer	  membrane.	  	  The	  periplasm	  is	  an	  oxidizing,	  energy-­‐deficient	  environment	  that	  is	  more	  crowded	  with	  proteins	  and	  polysaccharides	  than	  the	  cytoplasm	  [Pluckthun,	  A,	  Wulfing,	  C.	  (1994)].	  	  Furthermore,	  the	  periplasm	  is	  an	  extremely	  dynamic	   environment,	   constantly	   exchanging	   ions	   and	   small	  molecules,	  and	  responding	  to	  extracellular	  stress	  such	  as	  toxic	  molecules,	  pH	  changes,	  and	  heat.	  	  Proteins	  destined	  for	   the	  outer	  membrane	  must	  pass	  through	  the	  periplasm,	  often	  with	  the	  aid	  of	  chaperones.	  	  In	  prokaryotic	  cells,	  membrane	  proteins	  are	  synthesized	  by	  ribosomes	  associated	  with	  the	  plasma	  membrane.	  	  Similar	  to	  secretory	  and	  inner	  membrane	  (IM)	  proteins,	  the	  translocation	  of	  the	  nascent	  polypeptide	  chain	  of	  OMP	  across	   the	   IM	   is	   assisted	   by	   translocons,	   which	   are	   protein	   complexes	   creating	   a	  water-­‐filled	  channel	  in	  the	  IM	  [White,	  S.	  H.	  et.	  al.	  (2009),	  Gold,	  V.	  A.	  M.,	  Duong,	  F.	  and	  Collinson,	  I.	  (2007),	  Lizak,	  B.,	  Csala,	  M.,	  et.	  al.	  (2008),	  Rusch,	  S.	  L.	  and	  Kendall,	  D.	  A.	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(2007)].	  	  The	  process	  of	  OMP	  translocation	  through	  the	  periplasm	  and	  insertion	  into	  the	  OM	  is	  poorly	  defined.	   	  However,	   it	   is	  becoming	  clear	   that	   the	  process	  requires	  the	   assistance	   of	   periplasmic	   chaperones,	   proteins	   that	   bind	   to	   and	   stabilize	   the	  nascent	  OMP	  to	  prevent	  misfolding	  and	  precipitation,	  and	  potentially	  also	  assist	  the	  insertion	  of	  the	  proteins	  to	  their	  final	  destination	  in	  the	  OM	  [Pluckthun,	  A,	  Wulfing,	  C.	  (1994),	  Bos,	  M.	  P.,	  V.	  Robert,	  et	  al.	  (2007),	  Ruiz	  N.,	  Kahne	  D.,	  Silhavy	  T.J.	  (2006),	  Missiakas,	  D.,	  J.	  M.	  Betton,	  et	  al.	  (1996),	  Duguay	  A.	  R.,	  Silhavy	  T.	  J.	  (2004),	  Bernstein,	  H.D.	  (2000),	  Sijbrandi,	  R.,	  Urbanus,	  M.L.,	  et	  al.	  (2003)].	  	  	  
Several	   periplasmic	   molecular	   chaperones	   have	   been	   identified,	   including	  DegP,	  Skp,	  FkpA	  and	  SurA	  [Mogensen	  J.	  E.,	  and	  Otzen	  D.	  E.	  (2005),	  Sklar	  J.	  G.,	  Wu	  T.,	  et.	   al.,	   (2007),	   Stymest	   K.	   H.,	   and	   Klappa	   P.	   (2008)].	   	   Unlike	   the	   cytoplasmic	  chaperones,	   the	   periplasmic	   chaperones	   operate	   without	   the	   consumption	   of	  energy,	  as	  ATP	  is	  not	  present	  in	  the	  periplasm.	  	  In	  addition	  to	  molecular	  chaperones,	  several	   peptidyl-­‐prolyl	   isomerases	   and	   at	   least	   six	   disulfide	   bond	   reductases	   and	  isomerases	   have	   been	   identified	   in	   the	   periplasm	   [Behrens,	   S.,	   R.	   Maier,	   et	   al.	  (2001)].	  	  Despite	  the	  important	  role	  of	  chaperones,	  only	  a	  few	  have	  been	  discovered	  and	   examined.	   	   Among	   the	   chaperones,	   the	   interactions	   of	   Skp	   and	   several	   OMP	  substrates	  have	  been	  studied	  most	  extensively	  [Qu,	  J.,	  C.	  Mayer,	  et	  al.	  (2007),	  Chen	  R.	  and	  Henning	  U.	  (1996),	  Harms	  N.,	  Koningstein	  G.,	  et.	  al.	  (2001),	  Schafer	  U.,	  Beck	  K.	  and	  Muller	  M.	  (1999),	  Bulieris	  P.	  V.,	  Behrens	  S.,	  et.	  al.	  (2003)].	  	  	  
Cells	  lacking	  Skp	  are	  viable	  and	  show	  no	  signs	  of	  sickness	  [Rizzitello,	  A.	  E.,	  J.	  R.	  Harper,	  et	  al.	  (2001)]	  but	  express	  lower	  levels	  of	  OMPs	  [Chen	  R.	  and	  Henning	  U.	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Figure	  1.2	  	  OMP	  biogenesis	  involving	  periplasmic	  molecular	  chaperones	  SurA,	  Skp,	  and	  DegP.	  	  Nascent	  OMP	  polypeptides	  emerge	  from	  ribosomes	  and	  are	  translocated	  out	  of	  the	  cytoplasm	  by	  the	  Sec	  system	  via	  an	  C-­‐terminal	  signal	  peptide	  (red).	  	  In	  the	  periplasm,	  polypeptides	  are	  either	  met	   first	  by	  Skp/DegP	  or	  SurA.	   	  OMPs	   that	   are	  encoded	  with	  a	  N-­‐terminal	  signal	  peptide	  are	  assembled	   into	  the	  outer	  membrane	  by	  the	  YaeT	  complex.	  	  It	  is	  known	  that	  SurA	  interacts	  with	  the	  YaeT	  complex	  during	  the	  process	  of	  OMP	  assembly	  [Sklar,	   J.	  G.,	  T.	  Wu,	  et	  al.	   (2007)].	   	  By	  deduction,	   it	   is	  assumed	   that	   Skp/DegP	   also	   must	   interact	   with	   this	   complex	   when	   SurA	   is	   not	  present	  because	  certain	  OMPs	  must	  be	  assembled	  by	  YaeT.	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SurA	  is	  a	  periplasmic	  protein	  in	  E.	  coli	  that	  has	  dual	  functions	  as	  a	  molecular	  chaperone	  and	  peptidyl	  prolyl	  	  cis/trans	  isomerase	  (PPIase)	  [Rouviere,	  P.	  E.;	  Gross,	  C.	  A.	  (1996)].	   	  It	  has	  been	  purported	  to	  be	  the	  primary	  chaperone	  among	  the	  three	  major	  periplasmic	  chaperones:	  DegP,	  Skp,	  and	  SurA	  [Sklar,	  J.	  G.,	  T.	  Wu,	  et	  al.	  (2007)].	  	  SurA	  was	   originally	   described	   as	   a	   protein	  necessary	   for	   stationary	  phase	   growth	  [Tormo,	   A.,	   M.	   Almiron,	   et	   al.	   (1990)],	   but	   is	   not	   vital	   for	   growth	   under	   normal	  conditions	  [Justice,	  S.	  S.,	  D.	  A.	  Hunstad,	  et	  al.	  (2005)].	  	  At	  low	  temperatures,	  however,	  cells	  lacking	  SurA	  exhibit	  growth	  defects	  [Denoncin,	  K.,	  D.	  Vertommen,	  et	  al.	  (2010)].	  	  In	   addition,	   studies	   have	   shown	   that	   surA-­‐null	   mutants	   are	   more	   susceptible	   to	  certain	   antibiotics,	   bile	   salts,	   and	   SDS	   than	   surA-­‐containing	   strains,	   indicating	   a	  defective	  outer	  membrane	  [Denoncin,	  K.,	  D.	  Vertommen,	  et	  al.	   (2010),	  Watts,	  K.	  M.	  and	  D.	  A.	  Hunstad	   (2008),	   Justice,	  S.	  S.,	  D.	  A.	  Hunstad,	  et	  al.	   (2005),	  Behrens,	  S.,	  R.	  Maier,	  et	  al.	  (2001),	  Rouviere,	  P.	  E.	  and	  C.	  A.	  Gross	  (1996),	  Lazar,	  S.	  W.	  and	  R.	  Kolter	  (1996)].	  	  Furthermore,	  surA-­‐null	  strains	  form	  slightly	  mucoid	  colonies	  and	  are	  easily	  lysed	  during	  stationary	  phase,	  consistent	  with	  the	  phenotype	  with	  a	  defective	  outer	  membrane	   [Lazar,	  S.	  W.	  and	  R.	  Kolter	   (1996)].	   	  Similar	   to	  Skp,	   surA-­‐deficient	  cells	  show	  significantly	  lower	  levels	  of	  OMPs	  when	  compared	  with	  wild-­‐type	  (WT)	  cells	  [Rouviere,	  P.	  E.	  and	  C.	  A.	  Gross	  (1996)].	  	  Indeed,	  lower	  levels	  of	  OMPs	  could	  lead	  to	  a	  leaky	  outer	  membrane	  allowing	  the	  passage	  of	  small	  molecules	  normally	  excluded.	  	  	  
Both	  SurA	  and	  Skp	  were	  demonstrated	   to	  have	   functional	  redundancy	   in	  E.	  coli	  [Rizzitello,	  A.	  E.,	  J.	  R.	  Harper,	  et	  al.	  (2001)].	  	  A	  single	  deletion	  of	  surA	  results	  in	  an	  
	  9	  
up-­‐regulation	   of	   both	   DegP(~30-­‐fold)	   and	   Skp(~3-­‐fold),	   by	   Western	   blot	  analysis[Palomino,	   C.,	   E.	  Marin,	   et	   al.	   (2011)].	   	   A	   double	   deletion	   of	   surA	   and	   skp	  genes	   produces	   a	   synthetically	   lethal	   phenotype	   in	   rich	   media,	   resulting	   in	  bacteriostatic	   cells.	   	   In	   addition,	   these	   cells	   exhibit	   lowered	   levels	   of	   OMPs	   and	  changes	   to	   the	   cell	   morphology	   when	   compared	   to	   WT	   cells.	   	   Absence	   of	   DegP,	  another	   periplasmic	   chaperone/protease,	   along	   with	   SurA	   causes	   a	   bactericidal	  phenotype	  in	  E.	  coli.	  	  This,	  in	  contrast	  to	  the	  bacteriostatic	  effect	  seen	  in	  the	  double	  
surA	   skp	   mutant,	   is	   due	   to	   the	   lack	   of	   DegP	   protease	   activity	   in	   the	   periplasm.	  	  However,	   simultaneous	   deletion	   of	   skp	   and	   degP	   does	   not	   result	   in	   a	   lethal	  phenotype	  [Rizzitello,	  A.	  E.,	  J.	  R.	  Harper,	  et	  al.	  (2001)].	  	  Based	  on	  these	  findings,	  it	  is	  possible	   that	   there	   are	   two	   separate	   chaperone	   pathways,	   which	   are	   functionally	  redundant:	  one	  pathway	  involving	  SurA,	  and	  the	  other	  involving	  both	  DegP	  and	  Skp.	  	  	  
	  
1.4	  Characterization	  of	  SurA	  
Following	   the	   earliest	   studies	   on	   SurA,	   showing	   that	   it	   was	   required	   for	  stationary	   phase	   growth	   under	   special	   conditions,	   many	   pleiotropic	   defects	   were	  found	  in	  the	  cell	  envelope	  of	  surA-­‐null	  mutants.	  	  When	  sequenced,	  the	  surA	  gene	  was	  found	   to	   have	   regions	   of	   high	   sequence	   homology	  with	   the	   cytoplasmic	   peptidyl-­‐prolyl	   isomerase	   (PPIase),	   parvulin.	   	   These	   findings,	   coupled	  with	   the	  periplasmic	  location	   of	   SurA,	   indicated	   that	   SurA	   could	   assist	   the	   folding	   of	   extracytoplasmic	  proteins.	   	   To	   confirm	   that	   SurA	   assisted	   outer	  membrane	   protein	   folding,	   several	  OMPs	   were	   tested	   for	   trypsin	   sensitivity	   in	   WT	   and	   surA-­‐null	   mutants.	   	   OMPs	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extracted	   from	   the	   surA-­‐null	   strain	   were	   more	   sensitive	   to	   trypsin	   digestion,	  indicating	  mal-­‐folded	  OMPs	  [Lazar,	  S.	  W.	  and	  R.	  Kolter	   (1996)].	   	  This	  was	   the	   first	  evidence	   showing	   that	   SurA	   is	   involved	   in	   outer	   membrane	   protein	   folding.	   	   A	  subsequent	  study	  revealed	  that	  SurA	  has	  PPIase	  activity,	  as	  evidenced	  by	  its	  affinity	  for	   artificial	   proline-­‐containing	   substrates	   and	   catalysis	   of	   proline	   isomerization.	  	  This	  study	  also	  pointed	  out	  that	  SurA	  is	  involved	  in	  OMP	  maturation,	  and	  OMP	  levels	  are	   lowered	   due	   to	   reduced	   genetic	   transcription	   (σE	   induction)	   and	   improper	  folding	   in	   surA-­‐null	   mutants	   [Rouviere,	   P.	   E.	   and	   C.	   A.	   Gross	   (1996)].	   	   The	   early	  studies	  on	  SurA	  were	  grounded	  in	  observing	  phenotypic	  changes	  between	  WT	  and	  
surA-­‐null	  mutants.	   	  Later	  studies	  have	  been	  focused	  on	  the	  details	  of	  SurA	  function	  and	  which	  regions	  of	  the	  protein	  are	  implicated	  in	  the	  function.	  	  	  
SurA	  is	  composed	  of	  428	  amino	  acid	  residues	  with	  four	  domains:	  N-­‐terminal	  domain	  (N)	  (21-­‐175),	  PPIase	  1(P1)	  domain	  (176-­‐278),	  PPIase	  II(P2)	  domain	  (286-­‐384),	   and	  C-­‐terminal	  domain(Ct)	   (385-­‐428)	   [Bitto,	  E.	   and	  D.	  B.	  McKay	   (2002)].	   	   It	  has	   been	   shown	   that	   the	   chaperone	   activity	   of	   SurA	   operates	   independent	   of	   its	  PPIase	  activity.	  	  If	  either	  or	  both	  of	  	  ‘P’	  domains	  in	  SurA	  are	  deleted,	  the	  protein	  can	  still	  function	  in	  vivo	  with	  almost	  complete	  activity,	  as	  evidenced	  by	  plating	  on	  SDS-­‐EDTA,	   novobiocin,	   and	  measurements	   of	   σE	   induction	   [Behrens,	   S.,	   R.	  Maier,	   et	   al.	  (2001),	  Watts,	  K.	  M.	  and	  D.	  A.	  Hunstad	  (2008)].	   	  However,	  no	  individual	  domain	  is	  sufficient	  to	  rescue	  the	  surA-­‐null	  phenotype	  and	  both	  the	  N	  and	  C-­‐terminal	  domains	  are	   indispensible	   for	   proper	   function.	   	   To	   assess	   whether	   the	   N	   and	   C-­‐terminal	  domains	   alone	   exhibited	   chaperone	   activity	   in	   vitro,	   a	   N-­‐CtΔ(P1-­‐P2)	   mutant	   was	  tested	  for	  its	  ability	  to	  prevent	  aggregation	  of	  unfolded	  citrate	  synthase.	  	  Indeed,	  this	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mutant	  was	  capable	  of	   inhibiting	   thermal	  aggregation	  of	  citrate	  synthase,	  a	  classic	  assay	   for	  molecular	   chaperones	   [Behrens,	   S.,	   R.	   Maier,	   et	   al.	   (2001)].	   	   This	   result	  pointed	   out	   that	   the	   N	   and	   C-­‐terminal	   domains	   are	   largely	   responsible	   for	   the	  chaperone	  activity	  of	  SurA.	  	  	  
The	   crystal	   structure	   of	   SurA	   has	   been	   solved,	   revealing	   four	   distinct	  domains,	   consistent	   with	   sequence	   alignment	   result	   with	   other	   peptidyl-­‐prolyl	  isomerases	  [Bitto,	  E.	  and	  D.	  B.	  McKay	  (2002)].	  	  The	  N	  and	  C-­‐terminal	  domains,	  along	  with	   the	   P1	   domain	   form	   the	   “core	   module”	   of	   the	   protein,	   with	   the	   satellite	   P2	  domain	   separated	   by	   two	   polypeptide	   linkers	   of	   ~25-­‐30	   angstroms.	   	   In	   the	   core	  module,	  60%	  of	  the	  C-­‐terminal	  domain	  surface	  area	  interface	  is	  in	  contact	  with	  the	  N-­‐domain,	   showing	   high	   association	   between	   the	   two	   interfaces.	   	   In	   addition,	  topology	  images	  of	  the	  core	  domain	  show	  a	  deep	  crevice	  formed	  mostly	  by	  helices	  of	  the	  N-­‐terminal	  domain.	  	  This	  crevice	  was	  observed	  in	  the	  crystal	  structure	  of	  SurA,	  where	   a	   polypeptide	   (residues	   153-­‐164)	   binds	   in	   the	   neighboring	   core	   module	  region	  for	  approximately	  15	  angstroms	  in	  length.	  	  The	  short	  peptide	  only	  fills	  ~30%	  of	   the	   channel,	   which	   suggests	   that	   much	   longer	   polypeptides	   could	   be	  accommodated	  in	  this	  binding	  pocket	  [Bitto,	  E.	  and	  D.	  B.	  McKay	  (2002)].	  	  	  
SurA	   is	   substrate-­‐specific	   and	  was	   found	   to	   bind	   to	   an	   in-­‐vitro	   synthesized	  unfolded	  porin	  50-­‐fold	  more	  efficiently	  than	  other	  proteins	  of	  similar	  size	  [Behrens,	  S.,	   R.	   Maier,	   et	   al.	   (2001)].	   	   By	   using	   phage	   display,	   it	   was	   found	   that	   SurA	  preferentially	  binds	  proteins	  with	  an	  Ar-­‐X-­‐Ar	  motif,	  where	  Ar	  is	  an	  aromatic	  residue	  and	   X	   is	   any	   other	   residue	   [Bitto,	   E.	   and	   D.	   B.	   McKay	   (2003)].	   	   This	   motif	   is	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characteristic	  of	  integral	  OMPs	  in	  E.	  coli,	  suggesting	  that	  the	  primary	  targets	  of	  SurA	  are	  unfolded	  OMPs.	   	  Several	  heptapeptides,	  selected	  by	  phage	  display,	  were	  tested	  for	   binding	   with	   both	   SurA	   and	   SurA(ΔP2)	   and	   were	   found	   to	   bind	   with	   low	  micromolar	   affinity.	   	   The	   SurA(ΔP2)	   fusion	   had	   even	   higher	   (less	   than	   2-­‐fold)	  affinity	  for	  the	  short	  peptides	  than	  full-­‐length	  SurA,	  further	  demonstrating	  that	  the	  P2	  domain	  is	  not	  involved	  in	  chaperone	  activity.	  	  Futher,	  it	  was	  found	  that	  one	  of	  the	  heptapeptides	  (FTYMPPV)	  competes	  with	  unfolded	  OmpG	  and	  OmpF	  for	  the	  binding	  with	  SurA,	  indicating	  that	  the	  selected	  heptapeptides	  share	  overlapped	  binding	  site	  on	  SurA	  with	  unfolded	  OMPs.	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Figure	  1.3	  	  Crystallographic	  structure	  of	  SurA.	  	  The	  N-­‐terminal	  domain	  is	  shown	  in	  green,	  the	  P1	  domain	  is	  white,	  the	  P2	  domain	  is	  blue,	  and	  the	  C-­‐terminal	  domain	  is	  red.	  	  Structure	  was	  generated	  from	  the	  Swiss	  Protein	  Data	  Bank,	  ID:	  1M5Y	  [Bitto,	  E.	  and	  D.	  B.	  McKay	  (2002)].	  
A	  more	   detailed	   study	   on	   SurA	   binding	   focused	   on	   the	   interaction	   of	   SurA	  with	   specific	   regions	   of	   three	   OMPs	   (OmpF,	   LamB,	   and	   OmpA).	   	   Short	   (13-­‐mer)	  peptides	   were	   synthesized	   of	   the	   entire	   protein	   sequence	   for	   each	   OMP	   and	  immobilized	  onto	  a	  cellulose	  plate.	  	  SurA	  was	  found	  to	  bind	  the	  regions	  of	  the	  OMPs	  with	  the	  most	  aromatic	  content.	   	  73%	  of	  the	  good	  (>60%)	  binders	  and	  62%	  of	  the	  weak	  (>40%,	  <60%)	  binders	  contained	  the	  Ar-­‐X-­‐Ar	  or	  Ar-­‐Ar	  motif.	  	  Of	  the	  good	  and	  weak	   binders,	   the	  majority	   of	   them	   show	   a	   preference	   for	   generating	   beta-­‐strand	  secondary	  structure,	  based	  on	  predictions	  by	  the	  computer	  program,	  PsiPred	  [Xu,	  X.	  H.,	  S.	  Y.	  Wang,	  et	  al.	  (2007)].	  	  In	  addition,	  SurA	  lacking	  the	  P2	  domain	  bound	  to	  the	  same	  set	  of	  peptides	  as	  full-­‐length	  SurA,	  further	  confirming	  that	  the	  core	  domain	  of	  SurA	  is	  the	  active	  chaperone	  region	  [Hennecke,	  G.,	  J.	  Nolte,	  et	  al.	  (2005)].	  	  	  
The	  exact	  binding	  site	  on	  SurA	  has	  not	  been	  accurately	  determined,	  but	  it	  has	  been	  suggested	  to	  exist	  in	  the	  P1	  domain.	  	  This	  assertion	  is	  based	  on	  two	  findings:	  1)	  Crystal	   structures	   show	   that	   both	   the	   C-­‐terminal	   phage	   displayed	   dodecapeptide,	  NFTLKFWDIFRK	   [Xu,	   X.	   H.,	   S.	   Y.	   Wang,	   et	   al.	   (2007)]	   and	   the	   septapeptide,	  WEYIPNV,	  [Bitto,	  E.	  and	  D.	  B.	  McKay	  (2003)]	  bind	  to	  the	  P1	  domain	  of	  SurA.	  	  2)	  The	  binding	  of	  the	  dodecapeptide	  and	  septapeptide	  with	  the	  isolated	  P1	  domain	  of	  SurA	  was	  found	  to	  be	  five	  and	  50-­‐fold	  higher,	  respectively,	  than	  with	  full-­‐length	  SurA	  [Xu,	  
	  14	  
X.	   H.,	   S.	   Y.	   Wang,	   et	   al.	   (2007)].	   	   The	   sequence	   of	   the	   dodecapeptide	   defies	   the	  previously	   determined	   consensus	   motif	   Ar-­‐X-­‐Ar,	   but	   still	   contains	   33%	   aromatic	  content,	   in	  agreement	  with	  the	  notion	  that	  SurA	  recognizes	  polypeptide	  sequences	  rich	   in	   aromatic	   residues.	   	   These	   crystal	   structures,	   and	  one	   other	   from	   the	   same	  study	   (SurA(ΔP2)	   complexed	   with	   the	   C-­‐peptide),	   exist	   as	   the	   only	   conclusive	  evidence	  we	  have	  of	  a	  binding	  site	   for	  SurA.	   	  However,	   if	   the	  P1	  domain	  were	   the	  binding	   site	   of	   unfolded	   OMPs,	   then	   the	   surA-­‐null	   mutants	   containing	   surA	  constructs	  lacking	  the	  P1	  domain	  would	  not	  exhibit	  a	  WT	  phenotype.	   	  It	  should	  be	  noted	  that	  the	  surA	  constructs	  N-­‐P1-­‐Ct	  and	  N-­‐P2-­‐Ct	  are	  slightly	  more	  active	  in	  vivo	  and	   in	  vitro	   than	  the	  N-­‐Ct	  alone	  [Behrens,	  S.,	  R.	  Maier,	  et	  al.	   (2001)].	   	  Thus,	   the	  P1	  and	  P2	  domains	  might	  play	  an	  assistant	  role	  in	  the	  chaperone	  activity	  of	  SurA.	  	  Since	  the	   P1	   domain	   alone	   is	   insufficient	   to	   provide	   chaperone	   activity,	   but	   recognizes	  peptide	   domains	   characteristic	   of	   OMPs,	   it	   could	   be	   involved	   in	   substrate	  recognition.	   	   It	  was	  proposed	   that	   the	  crevice	   formed	  by	   the	  N-­‐domain	  provides	  a	  region	   for	   large	   segments	   of	   OMPs	   to	   bind	   with	   broad	   specificity,	   while	   the	   P1	  domain	  enhances	  selectivity	  of	   the	  SurA-­‐OMP	  complex	   [Xu,	  X.	  H.,	  S.	  Y.	  Wang,	  et	  al.	  (2007)].	   	   This	   would	   explain	   why	   the	   N-­‐Ct	   domains	   are	   able	   to	   function	   as	   a	  chaperone	  alone,	  but	  not	  as	  well	  as	  the	  N-­‐P1-­‐Ct	  domains	  together.	  	  
The	  specificity	  of	  SurA	  toward	  certain	  OMPs	  was	  confirmed	  in	  a	  proteomics	  study,	  where	  64	  OMPs,	  including	  23	  beta-­‐barrel	  proteins,	  were	  assessed	  for	  relative	  abundance	  in	  the	  outer	  membrane	  (OM)	  fraction	  of	  WT	  and	  surA-­‐null	  mutants.	   	  Of	  the	  23	  beta-­‐barrel	  proteins,	  eight	  of	   them	  were	   found	   to	  be	  negatively	  affected	  by	  lack	   of	   SurA.	   	   Consistent	  with	   previous	   results,	   the	  most	   studied	   SurA	   substrates,	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OmpF,	  OmpA,	  and	  LamB,	  were	  among	  this	  group.	  	  These	  three	  OMPs	  constitute	  the	  majority	   of	   OMPs	   in	   the	   outer	   membrane	   [Sklar,	   J.	   G.,	   T.	   Wu,	   et	   al.	   (2007)].	  	  	  However,	   the	   levels	  of	  only	   two	  proteins,	  LptD	  and	  FhuA,	  were	  reduced	  without	  a	  loss	   in	   genetic	   transcription.	   	   This	   suggests	   that	   LptD	   and	   FhuA	   could	   be	   ‘true’	  substrates	  of	  SurA,	  with	  normal	  levels	  of	  mRNA,	  but	  absence	  from	  the	  OM	  fraction	  in	  
surA-­‐null	  mutants	  [Vertommen,	  D.,	  N.	  Ruiz,	  et	  al.	  (2009)].	  	  Other	  OMPs	  also	  bind	  to	  SurA	  [Hennecke,	  G.,	  J.	  Nolte,	  et	  al.	  (2005)],	  but	  it	  is	  difficult	  to	  delineate	  whether	  the	  reduction	  of	  these	  OMPs	  in	  the	  OM	  fraction	  is	  a	  result	  of	  the	  lack	  of	  SurA	  or	  reduced	  mRNA	  levels.	   	   It	   is	  most	  probable	  that	   the	  reduction	  of	  mRNA	  is	  an	   indirect	  result	  (via	  σE	  induction)	  of	  the	  accumulation	  of	  unfolded	  and	  aggregated	  OMPs	  due	  to	  the	  lack	  of	  SurA	  in	  the	  periplasm.	  
Recently,	   SurA	  was	   implicated	   as	   a	   chaperone	   for	   the	   fimbrial	   usher,	   FimD	  [Justice,	  S.	  S.,	  D.	  A.	  Hunstad,	  et	  al.	  (2005)].	  	  FimD	  is	  involved	  in	  the	  polymerization	  of	  multimeric,	  adhesive	  pili,	  an	  essential	  component	  for	  the	  pathogenesis	  of	  E.	  coli	  by	  mediating	   attachment	   to	   endothelial	   tissue.	   	   Cells	   lacking	   SurA	   have	  much	   lower	  levels	   of	   FimD,	   as	   shown	   by	   Western	   blot	   with	   anti-­‐FimD	   antibody.	   	   The	  downstream	   effects	   of	   less	   FimD	   were	   also	   observed,	   where	   surA-­‐null	  uropathogenic	   E.coli	   (UPEC)	   cells	   were	   less	   able	   to	   mediate	   invasion	   of	   human	  endothelial	  cells	  in	  vitro.	  	  Both	  decrements	  were	  restored	  to	  50%	  or	  higher	  of	  wild-­‐type	  levels	  with	  plasmid	  constructs	  of	  full-­‐length	  surA,	  surAN+Ct,	  and	  surAN-­‐(P1	  or	  P2)-­‐Ct	  [Watts,	  K.	  M.	  and	  D.	  A.	  Hunstad	  (2008)].	  	  A	  subsequent	  study	  confirmed	  these	  findings	  in	  more	  detail	  by	  determining	  that	  FimD	  assembly	  in	  the	  outer	  membrane	  can	   be	   specifically	   attributed	   to	   the	   presence	   of	   SurA.	   	   An	   important	   effect	   of	   the	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absence	  of	  SurA	  in	  the	  cell	  is	  the	  upregulation	  of	  DegP,	  a	  periplasmic	  protease.	  	  One	  could	   conclude	   that	   reduced	   FimD	   in	   the	   outer	   membrane	   is	   just	   a	   result	   of	  increased	  levels	  of	  DegP	  degrading	  unfolded	  FimD.	  	  However,	  in	  the	  absence	  of	  DegP	  and	   SurA,	   the	   levels	   of	   folded	   FimD	   still	   dropped	   sharply,	   while	   the	   levels	   of	  unfolded	   FimD	   accumulated.	   	   Thus,	   DegP	   is	   responsible	   for	   degrading	   unfolded	  FimD,	  but	  SurA	  is	  required	  for	  proper	  insertion	  of	  folded	  FimD.	  	  It	  should	  be	  noted	  that	  strains	  lacking	  only	  DegP	  exhibit	  normal	  levels	  of	  FimD	  in	  the	  outer	  membrane	  [Palomino,	  C.,	  E.	  Marin,	  et	  al.	  2011].	  	  	  	  	  
	  
1.5	  Summary	  
Many	   studies	  have	   indicated	   the	   importance	  of	   SurA	   as	   a	   chaperone	   in	   the	  periplasm.	   	   SurA	   is	   an	   important	   component	   in	   OMP	   biogenesis	   and	   cells	   lacking	  SurA	  are	  much	  more	  susceptible	   to	  membrane	  perturbants	   than	  wild-­‐type	  strains.	  	  Despite	  all	  that	  is	  known	  about	  SurA,	  much	  is	  left	  a	  mystery.	  	  The	  exact	  binding	  site	  on	   SurA	   for	   full-­‐length	   OMPs	   is	   only	   postulated	   based	   on	   molecular	   modeling.	  	  Furthermore,	   there	   have	   been	   no	   in-­‐depth	   mutational	   studies	   to	   investigate	   the	  critical	   residues	   of	   SurA.	   	   My	   primary	   aim	   in	   this	   work	   was	   to	   explore	   the	  importance	   of	   the	   C-­‐terminus	   of	   SurA.	   	   I	   accomplished	   this	   in	   two	   ways:	   1)	   15	  single/double/triple	   site-­‐directed	   mutations	   were	   generated	   and	   these	   mutants	  were	  tested	  for	  activity	  through	  a	  minimum	  inhibitory	  concentration	  (MIC)	  assay	  of	  novobiocin,	  2)	   	  26	  mutants	  were	  generated	  where	  the	   last	  10	  amino	  acids	  of	  SurA	  were	  replaced	  by	  random	  10-­‐mer	  peptides	  and	  tested	  for	  MIC	  with	  novobiocin	  and	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SDS-­‐EDTA.	  	  A	  secondary	  aim	  was	  to	  mutate	  all	  of	  the	  aromatic	  residues	  at	  the	  N	  and	  C-­‐termini	  to	  alanine	  in	  single,	  double	  and	  triple	  mutation	  combinations,	  and	  test	  the	  MIC	  of	  novobiocin.	  	  Of	  the	  first	  15	  mutants	  generated	  from	  site-­‐directed	  mutations,	  only	  one	  mutant	  (E408:A)	  showed	  a	  significant	  (>3-­‐fold)	  reduction	  in	  MIC	  from	  WT.	  	  The	  resulting	  SurA	  protein	  (SurAE408A)	  was	  purified	  and	  characterized	  using	  circular	  dichroism,	   fluorescence	   spectroscopy,	   and	   fluorescence	  polarization	   (binding	  with	  OmpF).	  	  Of	  the	  aromatics	  that	  were	  mutated,	  only	  two	  of	  the	  triple	  mutants,	  Y(120,	  398,	  422):A	  and	  Y(125,	  398,	  422):A	  displayed	  low	  activity.	  	  The	  study	  of	  the	  SurA	  C-­‐terminal	  tail	  uncovered	  perhaps	  the	  most	  interesting	  and	  informative	  results.	  	  Of	  the	  26	  mutants	  selected,	  the	  MIC	  range	  for	  novobiocin	  was	  500-­‐1200	  and	  1.5%-­‐>5.0%	  SDS	   (with	   1mM	   EDTA),	   indicating	   a	   wide	   range	   of	   SurA	   activity.	   	   However,	   the	  sequences	   of	   these	   mutants	   revealed	   very	   little	   homology	   to	   wild-­‐type	   or	   even	  among	  the	  mutants	  of	  similar	  activity.	   	  Furthermore,	   the	  expression	   levels	  of	  SurA	  have	   little	   to	   do	   with	   the	   activity,	   as	   indicated	   by	   the	   MIC	   assays.	   	   Three	   of	   the	  mutants	  were	  chosen	  (two	  of	  high	  activity	  and	  one	  of	  modest	  activity)	   for	  protein	  characterization.	   	  The	   results	   indicated	   that	   the	  protein	   tertiary	   structure	  differed	  greatly	   from	   wild-­‐type.	   	   Taken	   together,	   it	   can	   be	   concluded	   that	   SurA	   is	   very	  tolerant	   to	   mutations	   of	   its	   sequence,	   which	   is	   consistent	   with	   its	   role	   in	   the	  interaction	  with	  nascent	  OMPs	  of	  various	  sequences	  and	  structures.	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Chapter	  II:	  Materials	  and	  Methods	  
2.1	  Materials	  





2.2	  Cloning,	  Expression,	  and	  Purification	  
E.coli	   surA-­‐null	   strain	   JW0052	   was	   obtained	   from	   the	   Coli	   Genetic	   Stock	  Center	   at	   Yale	   University,	   where	   surA	   was	   deleted	   from	   the	   genomic	   DNA	   and	  replaced	  with	  a	  kanamycin-­‐resistance	  cassette.	  	  surA	  gene	  was	  amplified	  using	  PCR	  from	  E.coli	   genomic	   DNA	   and	   cloned	   into	   pMalIII	   plasmid	   using	   Nde1	   and	   EcoR1	  restriction	  sites	  [Meng	  Zhong,	  unpublished	  result].	  	  
Plasmid-­‐encoded	   SurA	   was	   transformed	   in	   E.	   coli	   ER2566	   strain	   for	  expression.	  	  Protein	  expression	  and	  purification	  was	  conducted	  as	  described	  [Bitto,	  E.	   and	   D.	   B.	   McKay	   (2002)].	   	   Centrifugation	   was	   done	   using	   the	   Allegra	   25R	  Centrifuge	  (Beckman	  Coulter	  Indianapolis,	  IN).	  	  	  
2.3	  Site-­‐Directed	  Mutagenesis	  and	  Primer	  Sequences	  
Single	   residues	   in	   surA	   were	   altered	   by	   PCR,	   using	   the	   Quik	   change™	  protocol.	   	   Primer	   pairs	   are	   listed	   in	   Table	   1.	   	  WT	   surA	   gene,	   encoded	   on	   plasmid	  pMalIII,	  was	  used	  as	  the	  template,	  except	   in	  double	  mutants	  where	  one	  of	   the	  two	  codons	  was	  already	  mutated	  in	  the	  template.	  	  PCR	  parameters	  were	  as	  follows:	  60	  s	  at	  95°C,	   followed	  by	  22	  cycles	  of	  45	  s	  at	  95°C,	  60	  s,	  at	  58°C	  and	  13	  min.	  at	  68°C.	   ,	  ending	  with	  10	  min.	  at	  68°C.	   	  PCR	  was	  performed	  on	  a	  MJ	  mini	  Personal	  Thermal	  Cycler	  (BioRad,	  Hercules,	  CA).	  	  Following	  PCR,	  Dpn1	  restriction	  enzyme	  was	  added	  to	  the	  PCR	  reaction	  mixture	  to	  digest	  any	  methylated	  parent	  strands.	  	  Next,	  the	  PCR	  product	  was	  transformed	  into	  chemically	  competent	  XL	  Blue	  cells.	  	  Transformation	  was	  accomplished	  by	  adding	  ~0.1μg	  of	  plasmid	  DNA	  to	  competent	  cells	  on	  ice	  and	  incubating	  for	  30	  min.	   	  Next,	  cells	  were	  heat-­‐shocked	  at	  42°C	  for	  60	  s,	   followed	  by	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immediate	  incubation	  on	  ice	  for	  5	  min.	  	  1	  mL	  of	  LB	  broth	  was	  then	  added	  to	  the	  cells	  and	  incubated	  at	  37°C	  for	  at	  least	  45	  min.	  	  Cells	  were	  collected	  by	  centrifugation,	  re-­‐distributed	   in	   ~100uL	   of	   LB,	   and	   spread	   onto	   ampicillin-­‐containing	   agar	   plates.	  	  Plates	  were	   incubated	  overnight	   at	   37°C.	   	   At	   least	   4	   colonies	   from	   the	  plate	  were	  picked,	  shaken	  at	  250	  rpm	  at	  37°C	  to	  late-­‐log	  phase	  in	  LB	  before	  harvesting	  the	  cells	  and	   purifying	   the	   plasmid.	   	   Plasmid	  was	   purified	   using	   the	   plasmid	  mini-­‐prep	   kit	  from	  Denville	  Scientific.	  	  Following	  purification,	  the	  plasmid	  was	  sent	  for	  sequencing	  (Operon,	  Huntsville,	  AL).	  	  All	  sequences	  analyzed	  using	  CLC	  Sequence	  Viewer	  6	  (CLC	  bio,	   Aarhus,	   Denmark).	   	   Centrifugation	  was	   done	   using	   the	   260D	  microcentrifuge	  (Denville,	  Metuchen,	  NJ).	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Table	  2.1	  Primers	  used	  in	  this	  study	  
W(413):A	   CGGAAGAAGCAGCAAGCGCCATGCAGGAACAACGTGCC	  GGCACGTTGTTCCTGCATCGGGCTTGCTGCTTCTTCCG	  R(418):G	   GCTGGATGCAGGAACAAGGTGCCAGCGCCTACGTTAAA	  TTTAACGTAGGCGCTGGCACCTTGTTCCTGCATCCAGC	  A(421):W	   GCAGGAACAACGTGCCAGCTGGTACGTTAAAATCCTGAGC	  GCTCAGGATTTTAACGTACCAGCTGGCACGTTGTTCCTGC	  I(425):S	   GCCAGCGCCTACGTTAAATCCCTGAGCAACGGTGGTTC	  GAACCACCGTTGCTCAGGGATTTAACGTAGGCGCTGGC	  E(416):A	   GCAGCAAGCTGGATGCAGGCACAACGTGCCAGCGCC	  GGCGCTGGCACGTTGTGCCTGCATCCAGCTTGCTGC	  K(405):A	   CGCATGCTGATGAACCGTGCGTTCTCGGAAGAAGCAGCA	  TGCTGCTTCTTCCGAGAACGCACGGTTCATCAGCATGCG	  N(403):A	   GCATACCGCATGCTGATGGCCCGTAAGTTCTCGGAAGAAG	  CTTCTTCCGAGAACTTACGGGCCATCAGCATGCGGTATGC	  E(408):A	   GATGAACCGTAAGTTCTCGGCAGAAGCAGCAAGCTGGATG	  CATCCAGCTTGCTGCTTCTGCCGAGAACTTACGGTTCATC	  Q(415):A	   GAAGCAGCAAGCTGGATGGCGGAACAACGTGCCAGCGCC	  GGCGCTGGCACGTTGTTCCGCCATCCAGCTTGCTGCTTC	  F(406):A	   ATGCTGATGAACCGTAAGGCCTCGGAAGAAGCAGCAAGC	  GCTTGCTGCTTCTTCCGAGGCCTTACGGTTCATCAGCAT	  E(409):A	   GAACCGTAAGTTCTCGGAAGCAGCAGCAAGCTGGATGCAG	  CTGCATCCAGCTTGCTGCTGCTTCCGAGAACTTACGGTTC	  S(407):A	   GCTGATGAACCGTAAGTTCGCGGAAGAAGCAGCAAGCTGG	  CCAGCTTGCTGCTTCTTCCGCGAACTTACGGTTCATCAGC	  Y(398):A	   GCGCAGAAAGATCGTGCAGCGCGCATGCTGATGAACCG	  CGGTTCATCAGCATGCGCGCTGCACGATCTTTCTGCGC	  Y(422):A	   CAACGTGCCAGCGCCGCCGTTAAAATCCTGAGCAACGG	  CCGTTGCTCAGGATTTTAACGGCGGCGCTGGCACGTTG	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Table	  2.1	  (continued)	  
Y(128):A	   GGACTGAACTACAACACCGCTCGTAACCAGATCCGC	  GCGGATCTGGTTACGAGCGGTGTTGTAGTTCAGTCC	  Y(120):A	   GCGCAGCCGTCTGGCTGCCGATGGACTGAACTACAAC	  GTTGTAGTTCAGTCCATCGGCAGCCAGACGGCTGCGC	  Y(422):A	   CAACGTGCCAGCGCCGCCGTTAAAATCCTGAGCAACGG	  CCGTTGCTCAGGATTTTAACGGCGGCGCTGGCACGTTG	  Y(125):A	   GCTTACGATGGACTGAACGCCAACACCTATCGTAACCAG	  CTGGTTACGATAGGTGTTGGCGTTCAGTCCATCGTAAGC	  W(413):G	  R(418):G	   GGGATGCAGGAACAAGGTGCCAGCGCCTACG	  CGTAGGCGCTGGCACCTTGTTCCTGCATCCC	  S(407):A	  E(408):A	   GCTGATGAACCGTAAGTTCGCGGCAGAAGCAGCAAGCTGG	  CCAGCTTGCTGCTTCTGCCGCGAACTTACGGTTCATCAGC	  E(408):A	  E(409):A	   GAACCGTAAGTTCTCGGCAGCAGCAGCAAGCTGGATGCAG	  CTGCATCCAGCTTGCTGCTGCTGCCGAGAACTTACGGTTC	  Y(120):A	  Y(125):A	   GCTGCCGATGGACTGAACGCCAACACCTATCGTAACCAG	  CTGGTTACGATAGGTGTTGGCGTTCAGTCCATCGGCAGC	  Y(120):A	  Y(128):A	   GGACTGAACTACAACACCGCTCGTAACCAGATCCGC	  GCGGATCTGGTTACGAGCGGTGTTGTAGTTCAGTCC	  Y(125):A	  Y(128):A	   GGACTGAACGCCAACACCGCTCGTAACCAGATCCGCAAAG	  CTTTGCGGATCTGGTTACGAGCGGTGTTGGCGTTCAGTCC	  Y(398):A	  Y(422):A	   CAACGTGCCAGCGCCGCCGTTAAAATCCTGAGCAACGG	  CCGTTGCTCAGGATTTTAACGGCGGCGCTGGCACGTTG	  4AA	  C-­‐terminal	  deletion	   CAGCGCCTACGTTAAATAACTGAGCAACGGTGGTTCTC	  GAGAACCACCGTTGCTCAGTTATTTAACGTAGGCGCTG	  5AA	  C-­‐terminal	  deletion	   GTGCCAGCGCCTACGTTTAAATCCTGAGCAACGGTGGT	  ACCACCGTTGCTCAGGATTTAAACGTAGGCGCTGGCAC	  10AA	  C-­‐terminal	  deletion	   AGCTGGATGCAGGAACAGCGCTAAAGCGCCTACGTTAAAATCCTG	  CAGGATTTTAACGTAGGCGCTTTAGCGCTGTTCCTGCATCCAGCT	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Table	  2.1	  (continued)	  
11AA	  C-­‐terminal	  deletion	   GCTGGATGCAGGAACAATAAGCCAGCGCCTACGTTAAA	  TTTAACGTAGGCGCTGGCTTATTGTTCCTGCATCCAGC	  20AA	  C-­‐terminal	  deletion	   GCTGATGAACCGTAAGTTCTAAGAAGAAGCAGCAAGCTGG	  CCAGCTTGCTGCTTCTTCTTAGAACTTACGGTTCATCAGC	  	  
2.4	  Circular	  Dichroism	  (CD)	  Spectroscopy	  
CD	  was	  performed	  on	  a	  JASCO	  J-­‐810	  spectrometer	  (JASCO,	  United	  Kingdom)	  with	  1	  nm	  bandwidth,	  a	  0.1	  cm	  pathlength	  cuvette	   for	  secondary	  CD,	  and	  a	  1.0cm	  pathlength	   for	   tertiary	  CD.	   	  The	   sample	  was	  dialyzed	   three	   times	  overnight	   into	  a	  low	   salt	   buffer	   (25	   mM	   Phosphate	   buffer,	   100mM	   NaCl	   pH	   7.5)	   before	   the	   CD	  measurement.	   	   Blank	   scans	  were	   performed	  with	   the	   exterior	   dialysis	   buffer	   and	  subtracted	  from	  the	  measured	  data.	  	  	  
2.5	  Fluorescence	  spectroscopy	  	  Fluorescence	  polarization	  experiment	  and	  wavelength	  scans	  were	  performed	  with	   a	   Perkin	   Elmer	   LS-­‐55	   fluorescence	   spectrometer	   (Perkin	   Elmer,	   Waltham,	  Massachusetts).	   	   Scans	   were	   performed	   at	   room	   temperature.	   	   For	   the	   Trp	  fluorescence	   measurement,	   the	   protein	   was	   dialyzed	   overnight	   into	   a	   Phosphate	  buffer	  (20	  mM,	  pH	  8.0).	  	  The	  excitation	  wavelength	  was	  280	  nm.	  	  	  For	  the	  fluorescence	  polarization	  studies	  of	  fluorescein	  isothiocyanate	  (FITC)	  labeled	   SurA	   with	   outer	   membrane	   proteins,	   the	   excitation	   and	   emission	  wavelengths	   were	   492	   and	   515	   nm,	   respectively.	   	   SurA	   was	   first	   labeled	   with	  fluorescein	  isothiocyanate	  (FITC),	  the	  molar	  ratio	  of	  SurA	  and	  FITC	  is	  1:2.	  Unreacted	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FITC	   was	   quenched	   using	   Tris	   and	   removed	   through	   dialysis.	   FITC-­‐SurA	  concentration	   was	   determined	   by	   both	   the	   Bradford	   assay	   and	   fluorescence.	  	  Unfolded	  OMP	  was	  purified	  in	  the	  presence	  of	  8	  M	  urea.	   	  A	  solution	  containing	  1.3	  
µM	   FITC-­‐SurA	  was	   loaded	   in	   the	   cuvette,	   while	   small	   aliquots	   of	   unfolded	   OmpF	  were	  titrated	  into	  the	  FITC-­‐SurA	  solution.	   	  A	  one-­‐to-­‐one	  binding	  model	  fit	  the	  data	  reasonably	  well.	  	  	  
2.6	  SurA	  Activity	  Assay	  
The	  minimum	   inhibitory	   concentration	   (MIC)	   of	   primarily	   novobiocin	   was	  used	   to	   assess	   the	   activity	   of	   SurA	   in	  mutants.	   	   The	  MIC	   is	   the	   lowest	   amount	   of	  antibiotic	  needed	  to	  completely	  inhibit	  growth	  of	  the	  bacteria.	  	  ΔsurA	  JW0052	  E.	  coli	  cells	   were	   transformed	   with	   surA-­‐containg	   pMalIII	   plasmid	   containing	   ampicillin	  resistance	   gene.	   	   Following	   transformation,	   individual	   colonies	   were	   picked	   and	  grown	  to	  an	  optical	  density	  (OD)	  of	  0.1-­‐0.15.	   	  Cells	  were	  diluted	  10-­‐fold	  and	  a	  1uL	  spot	  was	  applied	  to	  the	  agar	  plates,	  followed	  by	  overnight	  incubation	  at	  37°C.	  	  Agar	  plates	  were	  prepared	  with	  1.5%	  agar	  and	  1X	  LB	  along	  with	  various	  concentrations	  of	  antibiotics	  by	  adding	  the	  appropriate	  amount	  of	  antibiotic	  stock	  to	  20mL	  of	  liquid	  agar	  mixture	  and	  allowing	   them	   to	   cool	  prior	   to	   inoculation.	   	   Following	  overnight	  incubation,	  the	  plates	  would	  be	  observed	  for	  colony	  formation.	   	  The	  concentration	  of	  drug	  at	  which	  no	  colonies	  formed	  was	  deemed	  the	  MIC	  for	  that	  mutant.	  	  	  
2.7	  Random	  Peptide	  Insertion	  at	  C-­‐terminus	  of	  SurA	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A	   stop	   codon	  was	   introduced	   into	   the	  WT	   surA	   gene	   at	   position	   419(Quik	  change™	  protocol),	   resulting	   in	  a	  10	  amino	  acid	  deletion	  at	   the	  C-­‐terminus	  during	  translation	  (denoted	  EC-­‐1).	  	  	  
	  
Figure	   2.1	   	   Gene	   sequences	   of	  WT	   surA	   and	   EC-­‐1	   surA	   construct	   beginning	  with	  Nhe1	  cutting	  site	  (blue)	  and	  containing	  intrinsic	  EcoR1	  cutting	  site	  (red).	  	  	  
	  
The	   last	   48	   nucleotides	   of	   the	   EC-­‐1	   surA	   gene	  were	   removed	   by	   double	   digestion	  using	  a	  designed	  NheI	  cutting	  site	  (Quik	  change™	  protocol)	  and	  an	  intrinsic	  EcoR1	  cutting	   site	   in	   the	   pMalIII	   vector.	   	   An	   HPLC-­‐purified	   DNA	   library	   (5’-­‐CGTTTGGATTAACCCGCTAGCTGGATGCAGGAACAACGT-­‐30nt-­‐TAACTGAATTCCATCCAGTGTAGTCGT-­‐3’)	   containing	   a	   random	   30-­‐mer	  oligonucleotide	  sequence	  (IDT,	  Coralville,	   IO)	   flanked	  by	  primers	  corresponding	  to	  the	  C-­‐terminal	  region	  of	  surA	  was	  amplified	  by	  PCR.	  	  	  The	  PCR	  product	  was	  column-­‐purifed	  and	   ligated	   into	   the	  EC-­‐1	  vector	  at	  16°C	   for	  at	   least	  6	  hours.	   	  The	   ligation	  product	  was	  transformed	  into	  the	  surA-­‐null	  strain,	  JW0052.	   	  The	  transformed	  cells	  were	  plated	  on	  solid	  LB-­‐agar	  media	  containing	  150μg/mL	  novobiocin	  and	  allowed	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to	  grow	  for	  48	  hours	  at	  37°C.	   	  The	  resulting	  colonies	  were	  grown	  in	  LB	  media	  and	  the	   surA-­‐containing	   plasmid	   DNA	   was	   purified	   using	   a	   plasmid-­‐MiniPrep	   kit	  (Denville,	   Metuchen,	   NJ).	   	   Following	   sequencing,	   the	   plasmid	   DNA	   was	   re-­‐transformed	  into	  the	  surA-­‐null	  strain	  and	  at	  least	  3	  colonies	  from	  each	  mutant	  were	  picked	  for	  analysis	  of	  MIC	  using	  novobiocin.	  
2.8	  6x-­‐Histidine	  Tag	  Insertion	  For	  Purification	  of	  Mutants	  
Three	  mutants,	  M2-­‐1,	  M2-­‐7,	  and	  M2-­‐9	  were	  chosen	   for	  protein	  purification	  and	  expression.	  	  Two	  rounds	  of	  PCR	  were	  used	  to	  sequentially	  add	  in	  a	  6X-­‐His-­‐tag.	  	  The	   F-­‐primer	   for	   both	   rounds	   containing	   an	   intrinsic	   BamH1	   cutting	   site	   was	  AAAGAGTTCTCTCAGGATCCAGGCTC	   and	   the	   first	   reverse	   primer	   varied	  with	   each	  mutant	   sequence:	   M2-­‐1:	   GTGGTGATGATGAGAACCACCCATGCTCGGAGTAGCAACC,	  M2-­‐7:	   GTGGTGATGATG	   AGAACCACC	   GGCGTTATGTCTCCAGTTCC,	   and	   M2-­‐9:	  GTGGTGATGATGAGAACCACC	   TCGCTCAGACAGAATCACC.	   	   The	   second	   reverse	  primer,	   containing	   an	   EcoR1	   cutting	   site	   was	   the	   same	   for	   all	   mutant	   proteins:	  ATAGCTATCCCAAGCTTAGTGATGGTGGTGATGATGAGAACC.	   	   Following	   PCR,	   the	  resulting	   fragments	   were	   column	   purified	   and	   digested	   with	   BamH1	   and	   HindIII	  restriction	   enzymes,	   then	   column	   purified	   again.	   	   In	   parallel,	   the	   surA	   gene	   was	  digested	   with	   BamH1	   and	   HindIII	   and	   purified	   by	   gel.	   	   The	   vector	   and	   fragment	  were	   ligated	   with	   DNA	   ligase	   for	   6	   hours	   at	   16°C.	   	   The	   ligation	   product	   was	  transformed	   into	   JW0052	   ΔsurA	   strain	   as	   described	   above.	   	   The	   plasmid	   was	  purified	   and	   sequenced.	   	   Correct	   sequences	  were	   transformed	   into	  ER2566	   strain	  and	  the	  proteins	  purified	  as	  described	  above.	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2.9	  Analysis	  of	  SurA	  Expression	  by	  Western	  Blot	  
One	  colony	  was	  picked	  from	  each	  mutant	  and	  grown	  overnight	  in	  15mL	  of	  LB	  media	   at	   37°C	  with	   shaking.	   	   The	  OD600	  was	   taken	   for	   each	   culture.	   	   13.5mL	  was	  taken	  from	  each	  culture	  and	  centrifuged	  at	  5500	  x	  g	  for	  20	  minutes.	  	  The	  cell	  pellet	  was	  re-­‐suspended	  in	  8mL	  of	  TRIS-­‐sucrose	  solution	  (20%	  sucrose,	  30mM	  TRIS,	  1mM	  EDTA,	   pH	   8.0)	   and	   incubated	   on	   ice	   with	   shaking	   for	   10-­‐20	   minutes.	   	   The	   cell-­‐containing	  solution	  was	  then	  centrifuged	  at	  8000	  x	  g	  for	  20	  minutes.	  	  The	  cell	  pellet	  was	  then	  re-­‐suspended	  in	  a	  normalized	  volume	  of	  5mM	  MgSO4	  based	  on	  the	  OD600	  of	  each	  culture.	   	  The	  resulting	  supernatant	  was	  run	  on	  a	  10%	  SDS-­‐polyacrylamide	  gel	  for	  50	  min.	  	  The	  proteins	  were	  transferred	  to	  a	  nitrocellulose	  membrane	  at	  20	  V	  for	  20	  min.	  The	  membrane	  was	  blocked	  overnight	  with	  1%	  BSA	  solution.	  	  Polyclonal	  anti-­‐SurA	  antibody	  was	  used	  at	  a	  1:4000	  dilution	  in	  PBS	  and	  incubated	  for	  at	  least	  2	  hours.	   	   Anti-­‐rabbit	   alkaline	   phosphatase	   antibody	   was	   used	   as	   the	   secondary	  antibody	  at	  a	  dilution	  of	  1:3000	  for	  1.5	  hours.	  The	  membrane	  was	  washed	  3	  times	  (PBS	  with	  1:1000	  dilution	  of	  Tween-­‐20)	  after	  each	  application	  of	  the	  antibody.	  	  The	  membrane	  was	  developed	  with	  solutions	  NBT	  and	  BCIP	  and	  quenched	  by	  washing	  with	  DI	  water.	  	  	  
2.10	  	  Limited	  Trypsin	  Digestion	  of	  SurA	  Mutants	  
	   Aliquots	  of	  each	  SurA	  mutant	   in	   the	  original	  dialysis	  buffer	   (20mM	  Sodium	  Phosphate,	   pH	   7.5)	   were	   added	   to	   separate	   1.5mL	   microcentrifuge	   tubes	   with	  approximately	   __ug	   of	   protein.	   	   Porcine	   trypsin	   was	   added	   to	   the	   SurA	   solution,	  corresponding	  to	  a	  trypsin:SurA	  mass	  ratio	  of	  1:500.	  	  Immediately	  after	  the	  addition	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Chapter	  III:	  Results	  and	  Discussion	  
3.1	  Importance	  of	  C-­‐terminus	  for	  SurA	  Function	  
The	  goal	  of	   this	   study	   is	   to	   identify	   the	  critical	   residues	  responsible	   for	   the	  chaperone	   activity	   of	   SurA.	   	   As	   discussed	   above,	   although	   SurA	   contains	   four	  domains,	  the	  two	  PPIase	  domains	  are	  not	  vital	  for	  the	  in	  vivo	  activity	  of	  SurA.	  	  The	  C-­‐terminal	   domain,	   however,	   has	   been	   shown	   to	   be	   critical	   for	   SurA	   function.	   	   As	  shown	  in	  Figure	  3.1,	  the	  C-­‐terminal	  domain	  is	  a	  long	  alpha-­‐helix	  followed	  by	  a	  single	  beta-­‐strand,	  which	  forms	  an	  anti-­‐parallel	  beta-­‐sheet	  with	  a	  beta-­‐strand	  from	  the	  N-­‐terminal	  domain.	  	  	  We	  hypothesize	  that	  this	  interaction	  is	  essential	  for	  the	  activity	  of	  SurA.	  	  To	  test	  this	  hypothesis,	  we	  created	  different	  constructs	  of	  truncated	  SurA,	  in	  which	  a	  small	  fraction	  of	  the	  sequence	  from	  the	  C-­‐terminal	  end	  was	  systematically	  truncated.	   	   The	   activities	   of	   the	   resultant	   mutants	   were	   examined	   through	  introducing	   each	   protein	   into	   a	   surA	   gene	   knockout	   strain	   and	   examining	   the	  susceptibility	   level	   of	   the	   stain	   toward	   an	   antibiotic	   novobiocin.	   	   The	   minimum	  inhibitory	   concentration	   (MIC)	   of	   novobiocin	   for	   the	   mutants	   can	   indicate	   the	  relative	  activity	  of	  SurA.	  	  	  	  E.	  coli	  strain	  JW0052	  (a	  ΔsurA	  strain)	  containing	  plasmid	  encoded	   wild	   type	   SurA	   (WT)	   was	   used	   as	   the	   positive	   control.	   	   As	   a	   negative	  control,	  JW0052	  containing	  the	  empty	  plasmid	  pMAL	  III	  was	  used.	  	  	  
SurA	   function	   is	   very	   sensitive	   to	   C-­‐terminal	   truncations.	   	   A	   deletion	   of	   as	  short	  as	  4	  amino	  acids	  yielded	  a	  significant	  drop	  of	  activity,	  while	  deletion	  of	  the	  last	  10	  amino	  acids	  completely	  abolished	  the	  activity	  of	  SurA	  (Figure	  3.1).	  	  As	  shown	  in	  Figure	  2,	   the	  C-­‐terminal	  beta-­‐strand	  (red)	  closely	  packs	  against	  a	  N-­‐terminal	  beta-­‐
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strand	   (green).	   	   When	   10	   residues	   of	   the	   C-­‐terminal	   tail	   are	   removed,	   this	  interaction	   is	   lost	   (Figure	   3.1,	   right),	   and	   this	   loss	   could	   destabilize	   the	   protein,	  preventing	   it	   from	  functioning	  properly.	   	  Additive	  sequential	  deletions	  from	  the	  C-­‐terminal	   end	   seem	   to	   affect	   the	   MIC	   by	   decreasing	   the	   value	   as	   the	   number	   of	  deleted	  amino	  acids	  increases.	   	  From	  2AA	  deletion	  to	  4AA	  deletion,	  the	  MIC	  values	  decrease	  by	  ~2-­‐fold	  with	   respect	   to	  WT.	   	   From	  4AA	  deletion	   to	  5AA	  deletion,	   the	  MIC	  values	  decrease	  further	  1.5-­‐fold.	  	  When	  10	  amino	  acids	  are	  deleted	  from	  the	  C-­‐terminus,	  the	  MIC	  value	  is	  equal	  with	  that	  of	  ΔsurA	  cells,	  indicating	  an	  inactive	  SurA	  protein.	  	  	  
	   	  




Table	  3.1	  	  MIC	  of	  Truncated	  SurA	  mutants	  
Mutation	   MIC	  of	  Novobiocin	  (ug/mL)	  	  WT	   1100	  ΔsurA	   100	  20AA	  C-­‐terminal	  deletion	   100	  11AA	  C-­‐terminal	  deletion	   100	  10AA	  C-­‐terminal	  deletion	   100	  5AA	  C-­‐terminal	  deletion	   250	  4AA	  C-­‐terminal	  deletion	   350	  2AA	  C-­‐terminal	  deletion	   256*	  *Liquid	   LB	   was	   used	   where	  MIC	   of	  WT	  was	   256	   ug/mL	   novobiocin.	   	   All	   other	   experiments	   were	  conducted	  using	  the	  agar	  plate	  method.	  	  
3.2	  	  Site-­‐Directed	  Mutagenesis	  of	  Residues	  at	  the	  C-­‐terminus	  of	  SurA	  
	   To	   further	   pinpoint	   key	   residues	   in	   the	   C-­‐terminal	   domain	   of	   SurA,	   we	  conducted	   BLAST	   search	   using	   the	   sequence	   of	   SurA	   from	   E.	   coli	   	   to	   identify	  conserved	   residues	   in	   proteins	   present	   in	   distant	   Gram-­‐negative	   species.	   	   Several	  conserved	   residues	   were	   identified	   and	   nine	   were	   chosen	   for	   site-­‐directed	  mutagenesis	   at	   the	   C-­‐terminus	   of	   the	   protein.	   	   The	   sequence	   alignment	   is	   shown	  below	  in	  Figure	  3.2.	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    NW  391TPKKKEIREKMFADKYEKRSKSYLERIRKSAMIEYR 
    ZM  391QPNFQQIHNQLQEDRVNKRAIRYLRDLRRDAIIDYR 
    VV  391SAMKNKAYRILFNRKFNEEVGAWMQELRAGAFVEII 
    BH  391LIFSLQDNKQKSPQELEILSEKYLKELRQVARIKSS 
    EC  391AAQKDRAYRMLMNRKFSEEAASWMQEQRASAYVKIL426 
                                                  :    .  *   *  : 
	  Figure	  3.2	  Sequence	  alignment	  of	  surA	  gene	  across	  several	  distant	  gram-­‐negative	  species.	   Nitrobacter	   winogradskyi	   (NW)	   Zymomonas	   mobilis	   (ZM)Vibrio	   vulnificus	  (VV)	  Bartonella	  henselae	   (BH)	   *	   indicates	   total	   conservation,	   :	   indicates	   conserved	  residue	  type,	  .	  indicates	  mostly	  conserved	  residue	  type.	  	  	  	  	   We	   have	   created	   nine	   single	   mutation	   mutants	   in	   which	   the	   indicated	  amino	  acid	  was	  replaced	  by	  alanine,	  glycine,	  or	  serine.	  	  The	  identities	  and	  locations	  of	   the	   mutated	   residues	   are	   shown	   in	   Figure	   3.3.	   	   JW0052	   containing	   plasmid	  encoded	  wild-­‐type	  SurA	  was	  used	  as	  the	  positive	  control.	  	  For	  the	  negative	  control,	  the	   surA-­‐containing	   pMal	   III	   plasmid	   was	   modified	   to	   exclude	   the	   signal	   peptide	  sequence	  (cyto	  SurA)	  necessary	  to	  translocate	  the	  SurA	  protein	  into	  the	  periplasm.	  	  Without	   the	   signal	   peptide	   sequence,	   SurA	   remains	   in	   the	   cytoplasm	   and	   is	   not	  functional.	  	  A	  summary	  of	  the	  MIC	  values	  of	  novobiocin	  for	  some	  of	  mutants	  in	  liquid	  LB	  broth	  culture	  can	  be	   found	   in	  Table	  3.2.	   	  The	  MIC	  values	  of	  novobiocin	   for	   the	  remaining	  mutants	  on	  LB	  agar	  media	  is	  presented	  in	  Table	  3.3.	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Figure	  3.3	   	  Structural	  image	  of	  SurA	  showing	  all	  residues	  on	  C-­‐terminus	  that	  were	  mutated.	   Structure	   was	   generated	   from	   the	   Swiss	   Protein	   Data	   Bank,	   ID:	   1M5Y	  [Bitto,	  E.	  and	  D.	  B.	  McKay	  (2002)].	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Table	  3.2	  	  MIC	  values	  of	  novobiocin	  for	  mutants	  at	  C-­‐terminus	  of	  SurA	  in	  liquid	  LB	  broth	  .	  	  
	  	  	   Novobiocin	  was	  added	  to	  the	  liquid	  culture	  at	  concentrations	  ranging	  from	  16-­‐256	   μg/mL	   at	   increments	   of	   2-­‐fold	   differences	   in	   concentration.	   	   The	   strain	  containing	  cytoplasmic	  SurA	  showed	  16-­‐fold	  decrease	   in	  MIC	   from	  WT,	  due	   to	   the	  absence	  of	  SurA	  in	  the	  periplasm.	  	  This	  shows	  that	  lack	  of	  SurA	  activity	  will	  render	  cells	   much	   more	   susceptible	   to	   bulky	   hydrophobic	   antibiotics	   than	   cells	   with	  
Mutation	   MIC	  of	  Novobiocin	  (ug/mL)	  WT	   256	  Cytoplasmic	  SurA	   64	  W(413):G	   200	  R(418):G	   200	  W(413):G	  R(418):G	   160	  I(425):S	   256	  E(416):A	   256	  K(405):A	   256	  E(408):A	   128	  N(403):A	   256	  Q(415):A	   256	  3AA	  C-­‐terminal	  deletion	  +	  I(425):S	  V(423):L	  	  A(421):W	   128	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properly	   functioning	  SurA.	   	  The	  only	   single	  mutation	  variant	   to	   show	  a	   consistent	  decrease	   in	  MIC	   of	   at	   least	   2-­‐fold	   from	   the	  WT	  was	   E(408):A.	   	  MIC	   values	   for	   all	  other	  mutants	  averaged	  out	  to	  be	  less	  than	  a	  2-­‐fold	  difference.	  	  The	  SurA	  construct	  containing	   3	   residue	   deletion	   at	   the	   C-­‐terminus	   plus	   I(425):S	   V(423):L	   A(421):W	  triple	  mutation	   was	   a	   result	   of	   a	   unintended	   single-­‐base	   deletion	   at	   the	   G(1263)	  position	  and	  subsequent	   frame-­‐shift	  mutation.	   	   Similar	   to	   the	  4AA	  deletion,	  which	  showed	  a	  difference	  of	  2-­‐fold	  decrease	  in	  MIC	  from	  WT	  (Table	  3.1),	  this	  mutant	  with	  3	   additional	   single	   mutations	   and	   a	   3AA	   deletion	   resulted	   in	   the	   same	   2-­‐fold	  decrease	   in	  MIC.	   	  This	   result	   shows	   that	   SurA	   is	   a	   very	   robust	  protein,	   capable	  of	  functioning	  with	  many	  substitutions	  at	  the	  C-­‐terminus.	  	  The	  importance	  of	  residues	  at	  the	  C-­‐terminus	  has	  been	  established	  by	  the	  deletion	  mutants	  from	  Table	  3.1,	  but	  the	  specific	  residue	  and	  even	  the	  class	  seems	  to	  be	  unimportant	   for	   function.	   	  The	  shift	   from	   alanine,	   a	   small	   hydrophobic	   residue	   to	   tryptophan,	   a	   bulky	   aromatic	  residue,	  coupled	  with	  the	  shift	  from	  isoleucine,	  a	  branched	  hydrophobic	  residue,	  to	  serine,	  a	  hydroxyl-­‐containing	  polar	  residue	  had	  little	  or	  no	  effect	  on	  the	  function	  of	  SurA.	   	   It	   is	  unlikely	   that	   the	  C-­‐terminal	   tail	   takes	   any	  part	   in	  binding	   the	   targeted	  unfolded	  proteins	  destined	  for	  the	  outer	  membrane,	  but	  it	  could	  play	  a	  vital	  role	  by	  associating	  with	  the	  N-­‐terminus	  for	  the	  overall	  stability	  of	  the	  protein.	  	  	  	   After	   many	   experiments	   and	   inconsistent	   results	   with	   the	   broth	   MIC	  method,	   agar	  plates	  were	  used	   for	   verifying	   the	  MIC	  values	  of	  mutants.	   	   The	   agar	  plate	   method	   provided	   easier	   determination	   of	   MIC	   by	   simply	   identifying	   the	  presence	   of	   visible	   colonies,	   rather	   than	   relying	   on	   optical	   density	   values,	   which	  were	  often	  inconsistent.	  	  However,	  as	  a	  result,	  there	  is	  a	  disparity	  in	  the	  numbers	  for	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the	  MIC.	   	  The	  MIC	  values	   from	   the	  agar	  plate	  method	  are	  much	  higher	   than	   those	  found	  when	  the	  LB	  broth	  method	  was	  used.	  	  There	  is	  no	  clear	  reasoning	  for	  this.	  	  It	  is	   possible	   that	   the	   agar	   has	   some	   antagonistic	   effect	   on	   the	   drug	   itself	   and	   its	  uptake	   into	   cells.	   	   It	   is	   also	   possible	   that	   some	   of	   the	   novobiocin	   is	   broken	   down	  during	  preparation	  of	  the	  agar	  plates.	  	  The	  drug	  must	  be	  added	  when	  the	  agar	  media	  is	  well	  above	  the	  gelling	  temperature	  of	  the	  agar	  (32-­‐45°C).	  	  At	  a	  temperature	  above	  45°C,	  the	  novobiocin	  could	  breakdown.	   	  Even	  though	  the	  reasoning	  for	  differences	  between	   the	   two	   methods	   is	   not	   well	   understood,	   the	   agar	   plate	   method	   still	  provided	  much	  more	  consistent	  data	  and	  was	  used	  for	  that	  reason.	  	  	  	   The	   relative	   MIC	   differences	   between	   JW0052	   containing	   wild	   type,	  cytoplasmic,	  and	  other	  SurA	  mutants	  are	  fairly	  consistent.	  	  The	  E(408):A	  mutant	  did	  not	  grow	  at	  a	  novobiocin	  concentration	  of	  a	  third	  the	  wild	  type	  MIC	  value	  in	  both	  the	  agar	  and	  broth	  methods.	   	  The	  ΔsurA	  strain	  was	  not	  tested	  using	  the	  broth	  method,	  but	  could	  be	  compared	  with	  cytoplasmic	  SurA	  from	  that	  data	  set	  because	  they	  have	  the	  same	  end	  result,	  lack	  of	  functioning	  SurA.	  	  These	  two	  have	  similar	  differences	  in	  MIC,	  approximately	  8-­‐fold,	  when	  compared	  with	  WT.	  	  Thus,	  the	  important	  value	  for	  MIC	  is	  not	  the	  raw	  number,	  but	  its	  relation	  to	  the	  controls.	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Table	  3.3.	   	  MIC	  values	  of	  novobiocin	  for	  mutants	  at	  C-­‐terminus	  of	  SurA	  on	  LB	  agar	  plates	  
Mutation	   MIC	  of	  Novobiocin	  (ug/mL)	  WT	  SurA	   1100	  ΔsurA	   100	  E(408):A	   350	  S(407):A	  E(408):A	   400	  E(408):A	  E(409):A	   400	  E(409):A	   450	  S(407):A	   500	  	  
	   Several	  more	  single	  and	  double	  mutation	  variants	  were	  tested	  for	  MIC	  using	  the	  agar	  plate	  method.	  	  None	  of	  these	  achieved	  a	  reduction	  in	  MIC,	  2-­‐fold	  or	  greater	  against	  WT,	   except	   the	   E(408):A	  mutant.	   	   One	  would	   expect	   that	   the	   two	   double	  mutation	  variants,	  which	  include	  the	  E(408):A	  mutation,	  would	  be	  equal	  or	  lower	  in	  MIC,	  but	  the	  averages	  came	  out	  higher.	  	  Due	  to	  the	  nature	  of	  the	  method	  and	  lack	  of	  resolution,	  it	  can	  be	  challenging	  sometimes	  to	  assess	  whether	  or	  not	  colonies	  have	  formed.	   	  Only	   increments	  of	  50	  μg/mL	  are	  used,	  so	   the	  MIC	  could	   lie	  between	   the	  two	  values.	   	   If	  more	   trials	  were	  conducted	  with	   these	   three	  mutants,	   the	  averages	  would	   likely	   converge.	   	   The	   important	   conclusion	   from	   this	   is	   that	   the	   adjacent	  amino	  acids	  on	  either	  side	  of	  E(408)	  have	  a	  minimal	  effect	  on	  the	  function	  of	  SurA.	  	  Furthermore,	  additive	  mutations	  do	  not	  necessarily	  equal	  the	  sum	  of	  the	  effects	  of	  each	  individual	  mutation.	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  3.3	  Characterization	  of	  SurAE408A	  and	  WT	  SurA	  
Following	   MIC	   tests,	   one	   of	   the	   mutants	   (E408:A)	   was	   chosen	   for	   structural	  characterization	   based	   on	   fluorescence	   emission	   and	   circular	   dichroism	   (CD)	  spectra.	   SurAE408A	   was	   chosen	   because	   of	   all	   the	   single	   mutations	   attempted,	   it	  seemed	   to	   have	   the	   most	   significant	   impact	   on	   the	   MIC	   of	   novobiocin	   in	   several	  independent	  experiments.	  	  	  
	  
	  
Figure	  3.4	  	  SDS-­‐PAGE	  gel	  of	  purified	  WT	  SurA	  and	  E(408):A	  SurA.	  Lane	  1:	  Molecular	  Weight	  Ladder,	  Lane	  5:	  E(408):A	  SurA	  Wash,	  Lane	  6:	  E(408):A	  SurA	  Fraction	  1,	  Lane	  7:	  E(408):A	  SurA	  	  Fraction	  2,	  Lane	  8:	  WT	  SurA	  Wash,	  Lane	  9:	  	  WT	  SurA	  Fraction	  1	  ,	  Lane	  10:	  WT	  SurA	  Fraction	  2	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SurAE408A	  was	  expressed	  and	  purified.	  	  Figure	  3.4	  showed	  the	  representative	  SDS-­‐PAGE	  .	  	  SureAE408A	  expressed	  as	  a	  similar	  level	  as	  the	  wild	  type	  SurA	  and	  could	  be	  purified	  with	  similar	  efficiency,	  indicating	  that	  the	  single	  point	  mutation	  did	  not	  have	  a	  drastic	  effect	  on	  the	  stability	  of	  the	  overall	  protein	  structure.	  	  E(408)	  is	  on	  the	  C-­‐terminal	  alpha-­‐helix	  and	  the	  acidic	  side-­‐chain	  faces	  away	  from	  the	  interface	  with	  the	  N-­‐terminus	  and	  is	  not	  closely	  associated	  with	  any	  other	  region	  of	  the	  protein.	  	  It	  is	   reasonable	   to	  postulate	   that	   the	  mutation	   to	  alanine	  will	  not	   severely	  affect	   the	  association	  between	  the	  N	  and	  C-­‐termini,	  thereby	  retaining	  the	  structural	  integrity	  of	   the	   core	  module.	   	   Using	   the	   purified	   protein,	   we	   have	   collected	   its	   CD	   spectra	  (Figure	   3.5	   and	   3.6)	   as	  well	   as	   intrinsic	   fluorescence	   spectrum	   (Figure	   3.7).	   	   The	  concentrations	   of	   both	   proteins,	   following	   dialysis,	  were	   approximately	   50	   μM,	   as	  measured	  by	  the	  absorbance	  at	  280	  nm.	  	  	   	  
Following	  purification	  and	  dialysis,	  the	  secondary	  structure	  of	  both	  SurAE408A	  and	  WT	  SurA	  was	   analyzed	  by	   circular	   dichroism	   (CD).	   	   Circular	   dichroism	   is	   the	  measurement	   of	   the	   difference	   in	   absorption	   between	   right	   and	   left	   circular-­‐polarized	  light.	  	  Secondary	  structure	  circular	  dichroism	  is	  used	  to	  probe	  the	  protein	  for	  alpha-­‐helices	  and	  beta-­‐sheets	  from	  190-­‐260	  nm	  with	  high	  reliability,	  where	  the	  chromophore	   is	   the	   peptide	   bond	   [Johnson,	   W.	   C.	   (1990)].	   	   A	   protein	   composed	  primarily	  of	  alpha-­‐helices	  will	  show	  a	  characteristic	  double	  trough.	   	  Those	  that	  are	  primarily	  anti-­‐parallel	  beta-­‐sheet	  will	  show	  a	  single	  trough	  and	  a	  large	  peak	  around	  195	   nm	   [Kelly,	   S.	   M.,	   T.	   J.	   Jess,	   et	   al.	   (2005)].	   	   Both	   SurA	   structures	   show	   the	  characteristic	  alpha-­‐helix	  double	  trough	  at	  ~	  222	  and	  210	  nm	  (Figure	  3.5).	  	  There	  is	  a	  small	  change	  of	  peak	  intensity	  between	  the	  plots	  of	  wild	  type	  and	  mutant	  SurA.	  	  No	  
	  40	  
peak	  shifts	  are	  observed	  in	  any	  spectra.	  	  From	  this	  CD	  plot,	  it	  can	  be	  concluded	  that	  there	   is	  still	  high	  helical	  contents	   in	  the	  structure	  of	  SurAE408A	  with	   little	  deviation	  from	  WT	  SurA.	  	  	  
	  
	  
Figure	  3.5.	  	  Circular	  Dichroism	  plot	  of	  SurA	  protein	  samples	  SurAE408A	  and	  WT	  SurA.	  	  MRE	  =	  Mean	  Residue	  Ellipticity	  (deg*cm2/dmol).	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UV	  CD	  spectra,	  only	  relative	  changes	  between	  a	  protein	  and	  mutants	  of	  that	  protein	  are	  reliable	  [Kelly,	  S.	  M.,	  T.	  J.	  Jess,	  et	  al.	  (2005)].	  	  In	  spite	  of	  its	  limitations,	  tertiary	  CD	  studies	  have	  yielded	  very	  important	  information	  regarding	  the	  structural	  changes	  of	  proteins	  subjected	  to	  site-­‐directed	  mutagenesis	  [Woody,	  A.	  Y.	  M.	  and	  R.	  W.	  Woody	  (2003),	  Boxer,	  D.	  H.,	  H.	  Zhang,	  et	  al.	  (2004)].  While	  the	  two	  plots	  were	  very	  similar,	  there	  is	  a	  small	  change	  of	  peak	  shape	  at	  around	  290	  nm,	  indicating	  a	  small	  change	  of	  the	  tertiary	  structure	  of	  SurAE408A	  (Figure	  3.6).	  	  	  
.	  	  	  
	  
Figure	  3.6.	  	  Circular	  Dichroism	  on	  protein	  samples	  SurAE408A	  and	  WT	  SurA	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The	  tertiary	  structure	  of	  WT	  SurA	  and	  SurAE408A	  were	   further	  probed	  using	  fluorescence	  spectroscopy.	  	  Fluorescence	  emission	  spectroscopy	  is	  a	  popular	  tool	  to	  reveal	   relative	   changes	   in	   protein	   tertiary	   structure.	   	   The	   chromophores	   in	   this	  method	   are	   the	   intrinsic	   tryptophan,	   tyrosine,	   and	   phenylalanine	   residues	   of	   the	  protein.	   	  Of	  the	  three,	  tryptophan	  contributes	  most	  to	  the	  fluorescence	  scan	  due	  to	  its	  high	  quantum	  yield	  and	  quenching	  of	  tyrosine	  residues	  [Teale	  (1960)].	  	  SurA	  has	  five	  intrinsic	  tryptophan	  residues,	  making	  it	  possible	  to	  analyze	  small	  changes	  in	  the	  tertiary	  structure.	   	  Fluorescence	  emission	  spectra	  are	  complicated	  to	  interpret,	  but	  the	  most	  important	  aspect	  of	  a	  scan	  is	  the	  position	  and	  intensity	  of	  the	  peak.	   	  This	  indicates	  the	  environment	  around	  the	  tryptophan	  residues	  or	  the	  relative	  exposure	  of	  tryptophan	  to	  the	  solvent	  .	  	  Tryptophan	  residues,	  which	  are	  buried	  in	  the	  protein	  are	   blue-­‐shifted	   relative	   to	   those	  which	   are	   exposed	   [Vivian,	   J.	   T.	   and	   P.	   R.	   Callis	  (2001)].	   	   However,	   scans	   of	   proteins	   containing	   more	   than	   one	   tryptophan	   are	  extremely	  difficult	  to	  interpret	  because	  the	  peak	  will	  be	  the	  sum	  of	  all	  of	  the	  signals	  from	  tryptophan.	  	  While	  some	  tryptophans	  could	  become	  buried,	  the	  others	  become	  exposed.	   	  On	   the	  other	  hand,	   if	   the	  protein	   is	   completely	  destabilized,	   this	  will	   be	  evident	  in	  the	  emission	  scan.	  	  Intensity	  of	  the	  peak	  has	  little	  to	  do	  with	  the	  position	  and	   orientation	   of	   tryptophan	   residues,	   but	   could	   be	   due	   to	   differences	   in	  concentration,	  or	  a	  combination	  of	  factors	  that	  are	  not	  fully	  understood.	  	  In	  the	  plot	  (Figure	  3.7),	   there	   is	   little	   difference	   in	   peak	  position,	   but	   a	   small	   change	  of	   peak	  intensity.	  	  The	  maximum	  emission	  peaks	  for	  WT	  SurA	  and	  SurAE408A	  were	  342.0	  nm	  and	   341.5	   nm,	   respectively.	   	   This	   is	   expected	   because	   the	   range	   of	   tryptophan	  emission	  is	  between	  308nm	  for	  fully	  buried	  residues,	  and	  355nm	  for	  fully	  exposed	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residues	  [Vivian,	  J.	  T.	  and	  P.	  R.	  Callis	  (2001)].  The	  lack	  of	  peak	  shift	  between	  the	  two	  proteins	  suggested	  that	  there	  was	  no	  large	  scale	  change	  of	  the	  global	  structure.	  	  
	  
Figure	  3.7.	  	  Fluorescence	  emission	  spectra	  for	  E(408):A	  SurA	  and	  WT	  SurA	  over	  the	  range	  290-­‐450	  nm.	   	  Excitation	  wavelength	  corresponding	  to	  maximum	  tryptophan	  absorbance	  was	  280nm.	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The	   Tm	   or	  melting	   temperature	   of	   the	   protein	   represents	   the	   temperature	  where	  50%	   of	   the	   protein	   is	   unfolded	   and	   is	   indicative	   of	   its	   stability.	   	   Proteins	   with	   a	  higher	   melting	   temperature	   are	   more	   stable	   than	   those	   with	   a	   lower	   melting	  temperature.	   	   Both	   protein	   samples	   have	   approximately	   the	   same	   melting	  temperature	  of	  55°C.	   	  The	  difference	  between	  the	  two	  protein	  samples	  is	  the	  slope	  of	  the	  curve	  (Figure	  3.9).	  SurAE408A	  has	  a	  slightly	  sharper	  slope	  than	  WT	  SurA.	  	  The	  sharper	   slope	   suggests	   greater	   cooperativity	   of	   protein	   folding	   in	   the	   mutant.	  	  However,	   the	   change	   is	   slight	   and	   more	   evidence	   would	   be	   needed	   to	   draw	   a	  definitive	  conclusion	  on	  the	  relative	  stability	  of	  these	  two	  proteins.	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Figure	  3.9	  This	  plot	  shows	  the	  relative	  percentage	  of	  WT	  SurA	  and	  E(408):A	  SurA	  unfolded	  during	  the	  temperature	  melt.	  	  
	  
	   Next,	  WT	  SurA	  and	  SurAE408A	  proteins	  were	  analyzed	  for	  function	  by	  testing	  the	   binding	   efficiencies	   to	   a	   denatured	   outer	  membrane	   porin	   (OmpF).	   	   This	  was	  accomplished	   by	   employing	   fluorescence	   polarization.	   	   Fluorescence	   polarization	  works	  by	  detecting	  changes	  in	  the	  tumbling	  of	  fluorescent	  molecules	  in	  solution.	  	  If	  a	  molecule	  binds	  another,	   then	   the	   tumbling	  will	   slow	  down	  and	   this	   is	  detected	  by	  the	   fluorometer	   [Jameson,	   D.	  M.	   and	   S.	   E.	   Seifried	   (1999)].	   	   Thus,	   it	   is	   a	   valuable	  method	  for	  observing	  binding	  between	  two	  molecules.	   	  OmpF	  was	  purified	  from	  E.	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amine	  on	  the	  side	  chain	  of	  lysine	  residues.	  	  Following	  dialysis	  to	  remove	  free	  FITC	  in	  the	   reaction	   mixture,	   SurA	   was	   added	   into	   a	   cuvette,	   followed	   by	   titration	   using	  OmpF	  to	  observe	  binding	  (Figure	  3.10).	  
	  
	  
Figure	  3.10	   	  This	  plot	  shows	  changes	   in	   fluorescence	  polarization	  with	   increasing	  concentrations	  of	  OmpF.	   	  WT	  SurA	  protein	  was	  boiled	   for	  5	  minutes	   to	   show	   that	  when	  it	  is	  unfolded,	  it	  binds	  very	  poorly	  to	  OmpF.	  	  	  
	  





















OmpF	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  (μM	  )	  
SurA	  Binding	  Afainity	  Plot	  
WT	  SurA	  E(408):A	  SurA	  Boiled	  WT	  SurA	  
Kd	  =	  1.64	  ±	  0.09	  μM	  	  Kd	  =	  1.37	  ±	  0.12	  μM	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tighter	  binding,	   the	  difference	   is	  minimal.	   	  Thus,	   the	  mutation	  E(408):A	   in	  SurA	   is	  not	  detrimental	  to	  the	  chaperone	  function	  of	  SurA,	  as	  evidenced	  by	  its	  ability	  to	  bind	  unfolded	  OmpF	  with	  the	  same	  affinity	  as	  WT	  SurA.	  	  
	   In	   conclusion,	   from	   the	   evidence	   of	   CD	   spectra	   and	   fluorescence	   emission	  spectra,	  the	  structure	  of	  SurAE408A	  is	  not	  significantly	  different	  from	  WT	  SurA.	   	  The	  peaks	   of	   both	   samples	   in	   all	   spectra	   shown	   had	   strong	   overlap	   with	   little	   or	   no	  changes	  in	  the	  position	  of	  the	  peak.	  	  The	  binding	  affinities	  with	  OmpF	  as	  measured	  
in	  vitro	  were	  also	  very	  similar.	  	  What	  caused	  the	  observed	  decrease	  in	  MIC	  values	  of	  novobiocin	   remains	   a	   mystery.	   	   More	   in-­‐depth	   structural	   analyses	   would	   be	  necessary	  to	  determine	  the	  cause	  of	  the	  partial	  loss	  of	  activity	  in	  SurAE408A.	  	  	  
	  
3.4	  Importance	  of	  Hydrophobic	  Interactions	  for	  SurA	  Function	  
	   Hydrophobic	  interactions	  can	  be	  a	  very	  important	  factor	  for	  a	  protein	  with	  a	  wide	   range	   of	   substrate	   specificity.	   	   Aromatic	   residues	   have	   bulky	   hydrophobic	  moieties	   that	   could	   be	   vital	   for	   the	   hydrophobic	   interactions	   necessary	   for	   low	  specificity	   binding.	   	   Only	   the	   C	   and	   N-­‐termini	   are	   vital	   for	   SurA	   function,	   so	   the	  aromatic	   residues	   at	   these	   two	   domains	   were	   the	   focus	   of	   this	   study.	   	   To	   test	  whether	   the	  aromatic	   residues	  at	   the	  C	  and	  N-­‐termini	  are	  vital	   for	   the	   function	  of	  SurA,	  a	  large	  selection	  of	  them	  were	  mutated	  to	  alanine.	  	  Four	  double	  mutants	  and	  five	   triple	  mutants	  were	  also	  constructed	   to	   further	  elucidate	   the	   role	  of	  aromatic	  residues	  in	  SurA	  function.	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Table	   3.4.	   	   MIC	   values	   for	   aromatic	   residues	   in	   the	   N-­‐terminus	   and	   C-­‐terminus	  mutated	   to	   alanine.	   	   Concentration	   of	   novobiocin	   on	   LB	   agar	   plates	   ranged	   from	  100μg/mL	  to	  500μg/mL.	  
Mutation	   MIC	  of	  novobiocin	  (μg/mL)	  W(413):A	   >500	  Y(398):A	   >500	  Y(128):A	   >500	  Y(120):A	   >500	  Y(422):A	   >500	  Y(125):A	   >500	  F(406):A	   500	  Y(398):A	  Y(422):A	   >500	  Y(120):A	  Y(128):A	   >500	  Y(120):A	  Y(125):A	   >500	  Y(125):A	  Y(128):A	   >500	  Y(398):A	  Y(422):A	  Y(120):A	   >500	  Y(398):A	  Y(422):A	  Y(125):A	   150	  Y(398):A	  Y(422):A	  Y(128):A	   150	  Y(398):A	  Y(422):A	  F(406):A	   >500	  Y(120):A	  Y(125):A	  Y(128):A	   >500	  	  
From	   the	  MIC	  data	  gathered	  here,	   it	   seems	   that	   these	  mutations	  have	   little	  effect	  on	  the	  function	  of	  SurA.	  The	  only	  single	  mutation	  that	  caused	  any	  decrease	  in	  MIC	   was	   F(406):A.	   	   All	   of	   the	   double	   mutants	   were	   found	   to	   be	   active	   at	  concentrations	   of	   novobiocin	   tested.	   	   At	   least	   three	   alanine	   substitutions	   were	  required	  to	  inhibit	  SurA	  function	  significantly	  and	  in	  both	  cases,	  Y(398)	  and	  Y(422)	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must	  be	  mutated.	  	  It	  is	  unclear	  why	  these	  two	  positions,	  coupled	  with	  either	  Y(125)	  or	  Y(128)	  are	  vital	  for	  proper	  function.	  	  It	  is	  surprising	  that	  the	  iterative	  mutations	  leading	  up	  to	  the	  triple	  mutant	  showed	  no	  loss	  in	  activity.	  	  It	  is	  possible	  that	  because	  these	   three	  positions	  are	   in	   three	  different	   corners	  of	   the	   core	  module,	  mutations	  will	   de-­‐stabilize	   the	   entire	   core	  module,	   cooperatively,	   to	   the	  point	  where	   it	   is	   no	  longer	   functional.	   	   The	  Y(398,	   422,	   120):A	  mutant	  did	  not	   exhibit	   this	   phenotype.	  	  This	  is	  likely	  due	  to	  the	  orientation	  of	  the	  aromatic	  side-­‐chain	  of	  Y(120):A.	  	  The	  side	  chain	   in	   Y(120)	   is	   exposed,	   and	   faces	   away	   from	   the	   core-­‐module,	  while	   those	   of	  both	   Y(125)	   and	   Y(128)	   are	   buried	   and	   face	   into	   the	   core	   module.	   	   Disrupting	  buried,	  bulky,	  hydrophobic	  residues	  has	  a	  much	  larger	  effect	  on	  the	  stabilization	  of	  the	  protein	  than	  disrupting	  those	  which	  are	  exposed.	   	  With	  these	  results,	  we	  show	  that	  additive	  mutations	  on	   the	  aromatic	  residues	  of	  SurA	  have	  a	  deleterious	  effect	  for	   the	   protein.	   	   Whether	   this	   is	   a	   result	   of	   decreased	   OMP	   binding	   or	   de-­‐stabilization	  of	  the	  protein	  cannot	  be	  answered	  with	  the	  MIC	  assay	  alone.	  	  	  
	  
3.5	  Sequence	  tolerance	  of	  C-­‐terminus	  of	  SurA	  
	   The	  data	  obtained	  from	  site-­‐directed	  mutagenesis	  has	  revealed	  that	  SurA	  is	  a	  very	   robust	   protein,	   and	   can	   accommodate	   many	   different	   single	   and	   double	  mutations	   at	   the	  C-­‐terminus	  without	   compromising	   the	   function.	   	  However,	  when	  the	  C-­‐terminus	  is	  truncated	  by	  10	  amino	  acids,	  the	  function	  is	  completely	  lost	  (Table	  3.1).	  	  The	  focus	  of	  this	  final	  study	  was	  to	  determine	  if	  the	  identity	  or	  class	  of	  the	  last	  10	  amino	  acids	  were	  important	  for	  function.	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   Toward	  this	  end,	  a	  surA	  vector	  (denoted	  EC-­‐1)	  was	  constructed	  in	  which	  the	  gene	   sequence	   corresponding	   to	   the	   last	   10	   residues	   was	   removed,	   while	   two	  restriction	   sites	   (NheI	   and	   EcoR1)	   were	   introduced	   to	   allow	   for	   a	   30nt	   random	  library	   to	  be	   inserted	  at	   the	  C-­‐terminus.	   	  EC-­‐1,	  when	   transformed	   into	  ΔsurA	   cells	  showed	   the	   same	   activity	   profile	   as	   the	   10	  AA	   truncated	   protein	  with	   novobiocin	  treatment	  (Table	  3.5).	  	  Due	  to	  the	  large	  difference	  between	  WT	  surA	  activity	  and	  EC-­‐1	   activity	   in	   the	   presence	   of	   novobiocin,	   a	  wide	   range	   of	  mutants	  with	   a	   random	  sequence	  at	  the	  C-­‐terminus	  could	  be	  identified.	  	  	  
	   Sequences	   that	   could	   restore	   the	   activity	   of	   SurAΔ419-­‐428	  were	   identified	  using	  a	  novobiocin	  assay.	   	  After	   ligation,	   the	   library	  of	  plasmids	  were	  transformed	  into	   JW0052	   and	   then	   plated	   on	   novobiocin-­‐containing	   agar	  media	   (150	   μg/mL).	  	  We	   determined	   at	   this	   concentration	   JW0052	   or	   JW0052	   containing	   EC1	   did	   not	  grow.	   Therefore,	   colonies	   that	   grew	   on	   the	   plate	   must	   have	   contained	   partially	  active	   SurA.	   To	   test	   the	   relative	   frequency	   of	   mutants	   that	   could	   recover	   SurA	  function,	  the	  number	  of	  colonies	  that	  grew	  with	  novobiocin	  selection	  pressure	  were	  divided	   by	   the	   number	   of	   colonies	   that	   grew	   without	   selection	   pressure.	   	   The	  average	  frequency	  was	  ~	  1.5%	  from	  three	  plates	  in	  each	  testing	  group.	  	  Thus,	  out	  of	  1.0	   x	   1013	   possible	   sequences,	   an	   estimated	   1.5	   x	   1011	   sequences	   will	   partially	  restore	  SurA	  activity.	  	  	  
	   Colonies	  that	  grew	  on	  novobiocin	  selecting	  plates	  were	  tested	  for	  MIC	  by	  first	  purifying	  the	  plasmid,	  and	  then	  picking	  three	  colonies	  following	  re-­‐transformation.	  	  This	  was	  done	  to	  ensure	  that	   the	  resistance	  to	  novobiocin	  was	  due	  to	   the	  plasmid	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and	  not	  a	  genomic	  mutation.	  	  In	  total,	  26	  colonies	  were	  chosen	  and	  analyzed,	  with	  a	  wide	   range	   of	   activity	   in	   the	   presence	   of	   novobiocin	   and	   SDS-­‐EDTA	   (Table	   3.5).	  	  Among	  the	  26	  mutants,	  14	  exhibited	  activity	  (MIC	  ≥	  900	  μg/mL)	  close	  to	  or	  better	  than	  WT	  for	  the	  novobiocin	  MIC	  assay,	  and	  11	  of	  them	  were	  viable	  when	  subjected	  to	   concentrations	   of	   5%	   SDS	   (1mM	   EDTA)	   or	   greater.	   	   The	   two	   assays	   differed	  somewhat	   in	   the	   selectivity	   relative	   to	  WT.	   	   This	   is	   not	   surprising,	   as	   these	   two	  chemicals	  affect	   the	  bacteria	   in	  very	  different	  ways.	   	  SDS	   is	  a	  harsh	  detergent	  and	  works	  by	  perturbing	  and	  dissolving	  the	  outer	  membrane	  directly.	  	  EDTA	  is	  added	  to	  chelate	  divalent	   cations,	  Mg2+	   and	  Ca2+,	   further	  destabilizing	   the	  outer	  membrane.	  	  Novobiocin,	  on	  the	  other	  hand,	  must	  traverse	  both	  membranes	  before	  it	  can	  act	  as	  an	  inibitor	  of	  DNA	  gyrase	  in	  the	  cytoplasm.	  	  	  
	   There	  seemed	  to	  be	  no	  pattern	  in	  the	  sequences	  of	  the	  mutants	  chosen.	  	  Only	  at	  position	  5	  is	  there	  any	  sequence	  homology	  between	  the	  mutants.	  	  At	  this	  position	  in	  the	  most	  active	  mutants	  (MIC	  ≥	  1000	  μg/mL	  novobiocin)	  there	  is	  either	  a	  valine,	  isoleucine,	  or	  methionine.	  	  WT	  SurA	  has	  a	  valine	  at	  this	  position,	  but	  both	  isoleucine	  and	  methionine	   are	   very	   good	   substitutions	   for	   valine.	   	   The	   role	   of	   valine	   at	   this	  position	   is	   not	   known,	   as	   it	   was	   never	   mutated	   in	   any	   of	   the	   previous	   work.	  	  However,	  it	  is	  not	  likely	  that	  it	  is	  vital	  for	  function	  because	  the	  mutant	  M4-­‐19	  has	  a	  cysteine	   substituted	   there	   and	   still	   exhibits	   good	   activity	   in	   the	   presence	   of	   both	  novobiocin	   and	   SDS-­‐EDTA.	   	   Thus,	   we	   conclude	   that	   the	   presence	   of	   the	   last	   10	  amino	  acids	  is	  vital	  for	  function,	  but	  the	  sequence	  is	  not	  necessarily	  very	  important.	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Table	  3.5	  	  Sequences	  of	  last	  10	  amino	  acids	  at	  C-­‐terminus	  of	  surA	  and	  MIC	  values	  of	  all	  mutants	  that	  were	  selected.	  	  Colonies	  were	  tested	  at	  concentrations	  of	  SDS	  from	  1.5%	   to	   5%	   on	   LB	   agar	  media,	   all	   containing	   1mM	  EDTA.	   	   Higher	   concentrations	  were	   not	   possible	   due	   to	   solubility	   issues.	   	   The	   range	   for	   novobiocin	   (nov.)	  concentrations	  was	  500	  μg/mL	  to	  1200	  μg/mL	  on	  LB	  agar	  media.	  	  The	  (*)	  indicates	  a	  stop	  codon.	  	  	  
	   Mutant	   MIC	   Sequence	  of	  Last	  10	  AA	  
	   Nov.	   SDS+EDTA	             
WT	  	   1100	   >5	   A S A Y V K I L S n 
	   	   	   	            M2-­‐9	  	   1200	   >5	   A C Q L V I L S E r M4-­‐1	   1200	   >5	   L G T T V I M P P * M4-­‐8	  	   1200	   5	   M T V Y I R L T H s 	   	   	             M4-­‐15	  	   1150	   >5	   F N T V V V Y L S s M4-­‐7	  	   1100	   4	   V S S K V S L C I r M4-­‐9	  	   1100	   4	   T I C H V A I P R g M4-­‐10	  	   1100	   5	   Q K A R M M G G G G M4-­‐13	  	   1100	   >5	   A L A W V I Y F C F M2-­‐1	  	   1100	   4	   A V G R V A T P S m 	   	   	             M4-­‐11	  	   1000	   5	   D K T L I C Y E H C M1-­‐1	  	   1000	   5	   L K A Y M F L S V l M1-­‐8	  	   1000	   3	   Q H I T v r V A G g M2-­‐5	  	   1000	   4	   A R I F V R L F G l 	   	   	             M4-­‐19	  	   950	   >5	   F F C R C F L T S d M3-­‐5	  	   900	   2.5	   V K S R A T V G S Q M4-­‐20	  	   900	   >5	   L L A V V I M S V q M3-­‐1	  	   875	   4	   I R W L K T V I I R M3-­‐6	  	   875	   2.5	   Q P A H V W V V L S 	   	   	             M4-­‐12	  	   750	   2.5	   A R V V G V V P M E M2-­‐4	  	   650	   4	   I R G P V V R V V Q M2-­‐10	  	   650	   3	   V C A R V R *    M2-­‐12	  	   650	   4	   L S T H I S V V S V M4-­‐21	  	   650	   >5	   A C A T V V W G G s M2-­‐8	  	   600	   2.5	   R R A W F F L C H G M2-­‐7	  	   600	   4	   D L L R R Y V S S S AK-­‐1	  	   500	   1.5	   A I T L L L G C S S 	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3.5.1	  Relative	  SurA	  Expression	  Among	  Mutants	  




Figure	  3.11a	   	  Western	  Blot	  using	  anti-­‐SurA	  antibody.	  	  From	  left,	  Lane	  1:	  WT	  SurA,	  Lane	  2:	  M3-­‐1	  SurA,	  Lane	  3:	  M2-­‐1	  SurA,	  Lane	  4:	  M2-­‐4	  SurA,	  Lane	  5:	  M2-­‐5	  SurA(re-­‐tested	  Fig.	  3.11d)	  ,	  Lane	  6:	  M1-­‐1	  SurA,	  Lane	  7:	  M1-­‐8	  SurA	  (re-­‐tested	  Fig.	  3.11d),	  Lane	  8:	  M3-­‐6	  SurA,	  Lane	  9:	  M3-­‐5	  SurA.	  	  	  
	  
Figure	   3.11b	   	  Western	   Blot	   using	   anti-­‐SurA	   antibody.	   	   From	   left,	   Lane	   1:	   M2-­‐12	  SurA,	   Lane	   2:	  M2-­‐10	   SurA,	   Lane	   3:	  M2-­‐9	   SurA,	   Lane	   4:	  M2-­‐8	   SurA,	   Lane	   5:	  M2-­‐7	  SurA,	  Lane	  6:	  EC-­‐1	  SurA,	  Lane	  7:	  WT	  SurA,	  Lane	  8:	  empty,	  Lane	  9:	  Purified	  SurA.	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Figure	  3.11c.	  	  Western	  Blot	  using	  anti-­‐SurA	  antibody.	  	  From	  left,	  Lane	  1:	  WT	  SurA,	  Lane	  2:	  	  ΔsurA,	  Lane	  3:	  M4-­‐21	  SurA,	  Lane	  4:	  M4-­‐20	  SurA,	  Lane	  5:	  M4-­‐19	  SurA,	  Lane	  6:	  M4-­‐15	  SurA,	  Lane	  7:	  M4-­‐13	  SurA,	  Lane	  8:	  M4-­‐12	  SurA	  Lane	  9:	  M4-­‐11	  SurA.	  	  Lane	  10	  :	  M4-­‐10	  	  
	  
Figure	  3.11d.	  	  Western	  Blot	  using	  anti-­‐SurA	  antibody.	  	  From	  left,	  Lane	  1:	  WT	  SurA,	  Lane	  2:	  EC-­‐1	  SurA,	  Lane	  3:	  M4-­‐1	  SurA,	  Lane	  4:	  M4-­‐7	  SurA,	  Lane	  5:	  M4-­‐8	  SurA,	  Lane	  
	  56	  
6:	  M4-­‐9	  SurA,	  Lane	  7:	  AK-­‐1	  SurA,	  Lane	  8:	  M1-­‐8	  SurA,	  Lane	  9:	  M2-­‐5	  SurA.	  	  Lane	  10	  :	  Purified	  SurA	  
	  
3.5.2	  	  Characterization	  of	  SurAM2-­‐1,	  SurAM2-­‐7,	  and	  SurAM2-­‐9	  SurA	  from	  the	  three	  mutants	  M2-­‐1,	  M2-­‐7,	  and	  M2-­‐9	  were	  chosen	  for	  protein	  characterization	   based	   on	   their	   activity	   and	   relative	   expression.	   	   All	   three	   had	  comparable	  expression	   levels:	   two	  (M2-­‐1	  and	  M2-­‐9)	  showed	  high	  activity	  and	  one	  (M2-­‐7)	   showed	  modest	   activity	   in	   the	  MIC	   assays.	   	   All	   three	  were	   expressed	   and	  purified,	  as	  described	  above,	  from	  the	  periplasm.	  	  Figures	  3.12	  and	  3.13	  show	  bands	  corresponding	  to	  SurA	  fractions	  of	  all	  three	  proteins.	  	  SurAM2-­‐9	  has	  a	  band	  on	  the	  gel	  (Fig.	  3.12)	  corresponding	  to	  a	  dimer.	  	  This	  is	  due	  to	  a	  cysteine	  introduced	  as	  part	  of	  the	   random	   peptide	   at	   the	   C-­‐terminus.	   	   SurA	   has	   no	   intrinsic	   cysteine	   residues,	  which	  explains	  why	  the	  WT	  SurA	  shows	  no	  dimer	  formation.	  	  Two	  SurA	  monomers	  will	   dimerize	   via	   an	   S-­‐S	   linkage	   between	   two	   cysteine	   residues	   in	   the	   oxidizing	  environment	   of	   the	   periplasm.	   	   This	   dimer	   formation	   is	   also	   seen	   on	   the	  western	  blot	  of	  M2-­‐9	  (Fig.	  3.11b),	  as	  well	  as	  with	  other	  mutants	  that	  have	  cysteine	  additions	  at	  the	  C-­‐terminus.	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Figure	  3.12.	  SDS-­‐PAGE	  gel	  of	  purified	  WT	  SurA	  ,	  M2-­‐1	  SurA,	  and	  M2-­‐9	  SurA.	  	  From	  left,	   Lane	   1:	  Molecular	  Weight	   Ladder,	   Lane	   2:	   Periplasmic	   fluid	   from	  M2-­‐1	   SurA,	  Lane	  3:	  M2-­‐1	  SurA	  Wash,	  Lane	  4:	  M2-­‐1	  SurA	  Fraction	  3,	  Lane	  5:	  Periplasmic	   fluid	  from	  M2-­‐9	  SurA,	  Lane	  6:	  M2-­‐9	  SurA	  Wash,	  Lane	  7:	  M2-­‐9	  SurA	  Fraction	  3,	  Lane	  8:	  Periplasmic	  fluid	  from	  WT	  SurA,	  Lane	  9:	  WT	  SurA	  Wash,	  Lane	  10:	  WT	  SurA	  Fraction	  3	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Figure	  3.13	  	  SDS	  PAGE	  gel	  of	  purified	  M2-­‐7	  SurA.	  	  From	  left:	  Lane	  1:	  M2-­‐7	  Fraction	  3,	  Lane	  2:	  M2-­‐7	  Fraction	  1,	  Lane	  3:	  M2-­‐7SurA	  Wash,	  Lane	  4:	  Molecular	  Weight	  Marker	  	   Following	  expression	  and	  purification,	  all	   three	  SurA	  mutant	  proteins	  were	  analyzed	  by	   secondary	  CD,	   tertiary	  CD,	   and	   fluorescence	   spectroscopy	   for	   relative	  structural	   changes.	   	   From	   the	   secondary	   CD	   plot,	   there	   are	   obvious	   differences	  between	   the	   mutant	   proteins	   and	   WT	   SurA.	   	   Surprisingly,	   there	   were	   large	  differences	   between	   the	   spectra.	   	   All	   mutants	   still	   maintain	   moderate	   levels	   of	  alpha-­‐helix	  content,	  but	  certainly	  some	  was	  lost	  with	  the	  substitutions	  made	  at	  the	  C-­‐terminus.	  	  The	  M2-­‐9	  is	  most	  different	  from	  the	  WT,	  with	  helical	  content	  dropped	  nearly	  50%.	   	  And	  yet,	   the	  mutant	   is	  completely	   functional	  as	  compared	   to	   the	  WT	  SurA.	   	  Interestingly,	  we	  found	  that	  M2-­‐9	  formed	  a	  dimer	  band	  in	  SDS-­‐PAGE,	  linked	  together	  via	  a	  Cys	  in	  the	  C-­‐terminus.	  We	  speculate	  that	  SurA	  might	  need	  to	  function	  as	   a	   dimer,	   and	   the	   presence	   of	   Cys	   in	   M2-­‐9	   stabilized	   the	   dimer,	   and	   therefore	  improved	  the	  activity	  of	  the	  mutant.	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Figure	   3.16	   	   Fluorescence	   emission	   spectra	   of	   WT	   SurA	   with	   mutants	   SurAM2-­‐1,	  SurAM2-­‐7,	   and	   SurAM2-­‐9.	   	   All	   traces	   were	   normalized	   to	   the	   concentration	   of	   each	  protein.	  	  Excitation	  wavelength	  was	  280	  nm.	  	  	  	   The	   tertiary	  CD	  plots	  and	   fluorescence	  emission	  curves	  reveal	  more	  clearly	  the	  differences	  between	  WT	  SurA	  and	  the	  SurA	  mutants.	  	  Just	  as	  with	  the	  secondary	  CD	  analysis,	   SurAM2-­‐9	  was	   the	  most	  different	   from	  WT	   in	  both	   the	   tertiary	  CD	  and	  fluorescence	   emission	   spectra.	   	   The	   peak	   shift	   and	   difference	   in	   intensity	   in	   the	  tertiary	  CD	  plots	  of	  the	  proteins	  indicates	  a	  change	  of	  three-­‐dimensional	  structure.	  	  Tertiary	   CD	   can	   indicate	   relative	   changes	   in	   three-­‐dimensional	   structure	   between	  samples,	  but	  is	  not	  precise	  in	  determining	  what	  those	  changes	  are.	  	  Thus,	  it	  can	  only	  be	  concluded	  that	  the	  mutants	  are,	  to	  some	  degree,	  structurally	  dissimilar	  to	  the	  WT	  SurA.	   	  The	  maximum	  emission	  peaks	   for	  WT	  SurA,	  SurAM2-­‐1,	  SurAM2-­‐7,	  SurAM2-­‐9	  are	  344.5,	  343.5,	  345,	  and	  348,	  respectively.	  	  SurAM2-­‐9	  is	  red-­‐shifted	  3.5	  nm	  with	  respect	  to	  WT	  SurA,	  while	   the	  other	   two	  are	  shifted	  by	  only	  1	  nm,	  at	   the	  most.	   	  From	  the	  putative	  model	  for	  intrinsic	  tryptophan	  fluorescence	  emission,	  it	  can	  be	  postulated	  that	  one	  or	  more	  of	   the	  tryptophan	  residues	   in	  SurAM2-­‐9	   is	  more	  exposed	  than	  WT	  SurA.	   	   Although	   these	   changes	   are	   slight,	   SurAM2-­‐9	   remains	   the	   most	   structurally	  distant	  species	  from	  WT	  SurA.	  	  It	  is	  somewhat	  surprising	  that	  SurAM2-­‐9	  and	  SurAM2-­‐1	  show	   so	  much	   difference	   from	  WT,	   because	   both	   proteins	  were	  more	   active	   than	  WT	   SurA	   in	   the	   novobiocin	  MIC	   assay,	   and	   SurAM2-­‐9	   was	   comparable	   in	   the	   SDS-­‐EDTA	  MIC	  assay.	   	  A	   few	  possibilities	  could	  explain	   this:	  1)	  The	  techniques	  used	  to	  characterize	  the	  protein	  structure	  are	  sensitive	  to	  changes	  which	  are	  not	  important	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for	   SurA	   function,	   2)	   SurA	   can	   accommodate	   a	   wide	   range	   of	   slight	   structural	  changes,	   which	   retain	   or	   even	   enhance	   function,	   or	   3)	   The	   changes	   observed	   are	  artifacts	   and	   not	   indicative	   of	   the	   actual	   structure	   of	   the	   proteins.	   	   The	   second	  possibility	   seems	  most	  plausible	  due	   to	  number	  of	   active	   SurA	  mutants	   that	  were	  generated	   and	   the	   percentage	   that	   recover	   function	   from	   the	   truncated	   SurA	  template.	  	  Since	  there	  is	  virtually	  no	  pattern	  in	  the	  primary	  sequence	  of	  the	  last	  10	  residues	  of	  the	  SurA	  mutants,	  one	  might	  conclude	  that	  it	  is	  unlikely	  that	  there	  exists	  a	  pattern	  in	  the	  resulting	  secondary	  structures.	  	  However,	  this	  is	  not	  easy	  to	  predict.	  	  The	   last	   10	   residues	   of	  WT	   SurA	   form	   a	   beta-­‐strand	  which	   associates	  with	   an	  N-­‐terminal	  beta	   strand	   to	   form	  anti-­‐parallel	  beta	   sheet.	   	  The	  propensity	   for	  primary	  sequences	   to	   form	  beta-­‐strands	   is	  believed	   to	  be	  modulated	  primarily	  by	   the	   local	  environment,	   and	   the	   side	   chains	   are	   thought	   to	   be	   important	   for	   stabilizing	   the	  beta-­‐strand	  [Baldi	  and	  Chang	  2005].	  	  Thus,	  an	  alternate	  hypothesis	  is	  that	  there	  are	  many	  different	  sequences	  that	  can	  form	  the	  beta-­‐strand	  at	  the	  C-­‐terminus	  based	  on	  the	   local	   environment,	   but	   some	   are	   stabilized	   to	   a	   higher	   degree	   than	   others.	   	   A	  decrease	  in	  the	  stability	  of	  the	  beta	  sheet	  between	  the	  N	  and	  C-­‐termini	  could	  alter	  the	  tertiary	  structure	  of	  the	  protein,	  thereby	  accounting	  for	  the	  differences	  seen	  in	  figures	   above.	   	   From	   the	   C-­‐terminal	   truncation	   results	   (Table	   3.1),	   it	   was	  determined	  that	  the	   last	  10	  residues	  are	  vital	   for	  function,	  thus	  the	  presence	  of	  an	  interacting	  beta-­‐strand	  is	  necessary	  at	  the	  C-­‐terminus.	  	  However,	  we	  postulate	  that	  a	  slight	  decrease	  in	  the	  stability	  of	  this	  interaction	  is	  not	  deleterious	  to	  the	  function	  of	  the	  protein.	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To	  further	  characterize	  the	  stability	  of	  the	  proteins	  in	  vitro,	  each	  of	  the	  SurA	  mutants	   were	   subjected	   to	   limited	   trypsin	   digestion.	   	   Trypsin	   is	   a	   protease	   that	  cleaves	  polypeptides	  at	  the	  carboxyl	  side	  of	  arginine	  and	  lysine	  residues.	  	  All	  protein	  levels	   were	   normalized	   and	   trypsin	   was	   allowed	   to	   digest	   for	   61	  minutes	   before	  heat	   inactivation	   along	  with	   SDS	   and	  DTT	   (a	   reducing	   agent	   for	   disulfide	   bonds).	  	  Samples	  were	  removed	  at	  1	  minute	  and	  every	  10	  minutes	  after	  that	  until	  61	  minutes	  had	   passed	   (Figures	   3.17-­‐3.20).	   	   Figures	   3.22	   and	   3.23	   show	   the	   same	   digestion,	  except	  samples	  were	  removed	  before	  and	  immediately	  following	  trypsin	  addition.	  	  	  
	  
Figure	   3.17	   	   Trypsin	   digestion	   of	  WT	   SurA	   on	   15%	   SDS	   gel.	   	   From	   left,	   Lane	   1:	  Molecular	  Weight	  marker.	  	  Lane	  2:	  Trypsin	  without	  SurA.	  	  Lanes	  3-­‐9:	  SurA	  digestion	  starting	  at	  1	  minute	  and	  increasing	  at	  10	  minute	  intervals	  to	  61	  minutes.	  	  Lane	  10:	  Trypsin	  without	  SurA.	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Figure	  3.18	   	   Trypsin	  digestion	  of	  M2-­‐1	  SurA	  on	  15%	  SDS	  gel.	   	   Lane	  1:	  Molecular	  Weight	  marker.	  	  Lane	  2:	  Trypsin	  without	  SurA.	  	  Lanes	  3-­‐9:	  SurA	  digestion	  starting	  at	  1	  minute	  and	  increasing	  at	  10	  minute	  intervals	  to	  61	  minutes.	  	  	  
	  
Figure	  3.19	   	   Trypsin	  digestion	  of	  M2-­‐9	  SurA	  on	  15%	  SDS	  gel.	   	   Lane	  1:	  Molecular	  Weight	  marker.	  	  Lane	  2:	  Trypsin	  without	  SurA.	  	  Lanes	  3-­‐9:	  SurA	  digestion	  starting	  at	  1	  minute	  and	  increasing	  at	  10	  minute	  intervals	  to	  61	  minutes.	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Figure	   3.20	  Trypsin	   digestion	   of	  M2-­‐7	   SurA	   on	   15%	   SDS	   gel.	   	   Lane	   1:	  Molecular	  Weight	  marker.	  	  Lanes	  2-­‐8:	  SurA	  digestion	  starting	  at	  1	  minute	  and	  increasing	  at	  10	  minute	  intervals	  to	  61	  minutes.	  Lane	  9:	  Trypsin	  without	  SurA.	  	   Limited	  trypsin	  digestion	  of	  WT	  SurA	  and	  SurA	  mutants	  revealed	  surprising	  results.	   	   The	   two	   most	   active	   mutants	   (SurAM2-­‐1	   and	   SurAM2-­‐9)	   are	   extremely	  susceptible	  to	  cleavage	  by	  trypsin,	  with	  almost	  complete	  digestion	  occurring	  within	  1	   minute	   (Fig.	   3.18	   and	   3.19).	   	   SurAM2-­‐7	   lasted	   slightly	   longer,	   with	   complete	  digestion	   occurring	   between	   10	   and	   20	   minutes	   (Fig.	   3.20).	   	   WT	   SurA	   was	  susceptible	   to	   cleavage,	   but	   even	   after	   61	   minutes,	   a	   significant	   band	   was	   still	  visible,	  indicating	  incomplete	  digestion.	  	  To	  rule	  out	  the	  possibility	  that	  the	  protein	  was	  degraded	  prior	   to	  digestion,	  a	  separate	  experiment	  was	  performed	  where	   the	  samples	  were	  removed	  just	  prior	  to	  trypsin	  addition	  (Fig.	  3.22	  and	  3.23).	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Figure	   3.21	   	   Crystal	   structure	   of	   full-­‐length	   SurA	   with	   proposed	   cutting	   sites,	  K(278)	   and	  K(388),	   for	   trypsin.	   	   The	   region	   between	  V(386)	   and	  D(395)	  was	   not	  resolved	   in	   the	   crystal	   structure,	  but	   it	   is	  presumed	   that	  K(388)	   lies	  very	   close	   to	  K(278)	  on	  the	  adjacent	  linker	  polypeptide.	  Structure	  was	  generated	  from	  the	  Swiss	  Protein	  Data	  Bank,	  ID:	  1M5Y	  [Bitto,	  E.	  and	  D.	  B.	  McKay	  (2002)].	  
	  
Perhaps	  the	  most	  interesting	  finding	  of	  this	  experiment	  is	  the	  fact	  that	  all	  of	  the	  SurA	  mutants	  were	  digested	  to	  the	  same	  sized	  fragment,	  which	  was	  resistant	  to	  further	  digestion.	   	   Consequently,	   there	  must	  be	  an	  exposed	   fragment	  of	  ~	  16	  kDa	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connected	   to	   a	   tightly	   packed	   fragment	   that	   is	   ~	   30	   kDa.	   	   We	   propose	   that	   the	  cutting	  site	  is	  K(278)	  ,	  which	  is	  positioned	  in	  the	  middle	  of	  one	  of	  the	  linker	  regions	  between	   the	   core	   domain	   and	   the	   satellite	   P2	   domain(Fig.	   3.21).	   	   If	   spliced,	   the	  resulting	  molecular	  weights	  of	  the	  core	  domain	  and	  P2	  domain	  would	  be	  29.1	  kDa	  and	  16.8	  kDa,	  respectively.	   	  The	  primary	  fragment	  on	  the	  gel	  runs	  in	  the	  middle	  of	  the	  35	  kDa	  marker	  and	  25kDa	  marker,	  and	  the	  smaller	  fragment	  can	  be	  seen	  most	  easily	  on	  Figure	  19,	   just	  below	   the	  dye	  band.	   	  Although	   these	   fragments	   are	  most	  likely	  the	  core	  domain	  and	  satellite	  P2	  domain,	  only	  analysis	  by	  mass	  spectrometry	  can	  confirm	  this	  with	  accuracy.	  	  There	  are	  a	  few	  other	  fragments	  present	  on	  the	  gels,	  particularly	   in	   the	  case	  of	  Figure	  19.	   	  This	   is	   likely	  due	   to	   the	  presence	  of	  dimers.	  	  DTT	  was	  not	  added	  until	  after	   the	  digestion	  was	  completed,	  so	   these	  dimers	  were	  present	  during	  the	  digestion.	  	  	  
This	   finding,	   although	   very	   interesting,	   is	   difficult	   to	   explain.	   	   When	  substitution	   at	   the	   C-­‐terminus	   occurs,	   in	   all	   three	   cases,	   SurA	   becomes	   very	  susceptible	  to	  trypsin	  digestion.	  	  Taken	  alone,	  this	  would	  suggest	  that	  the	  protein	  is	  very	   unstable	   in	   vivo,	   and	   in	   fact,	   it	   might	   be.	   	   Nevertheless,	   if	   our	   hypothesis	  regarding	   the	   cutting	   site	   is	   correct,	   then	   it	   would	   not	  matter	   if	   SurA	   is	   digested	  easily	  in	  vivo,	  because	  SurA(ΔP2)	  is	  just	  as	  active	  as	  full-­‐length	  SurA	  [Hennecke,	  G.,	  J.	  Nolte,	  et	  al.	   (2005),	  Behrens,	  S.,	  R.	  Maier,	  et	  al.	   (2001)].	   	  This	   finding	  corroborates	  the	   results	   from	   tertiary	   CD	   and	   fluorescence	   spectroscopy	   by	   showing	   that	   the	  mutant	   proteins	   are	   in	   fact,	   structurally	   different.	   	   The	   substitutions	   at	   the	   C-­‐terminus	  could	  loosen	  the	  interaction	  between	  the	  N	  and	  C-­‐termini,	  creating	  a	  more	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flexible	   structure	   and	   leaving	   the	   P2	   domain	   tethered,	   but	   very	   accessible	   to	  digestion.	  
	  
Figure	  3.22	  	  Trypsin	  digestion	  of	  WT,	  M2-­‐1,	  and	  M2-­‐9	  SurA	  proteins	  for	  60	  minutes	  on	  20%	  SDS	  gel.	   	  From	  left,	  Lane	  1:	  WT	  SurA,	  no	  trypsin,	  Lane	  2:	  WT	  SurA	  at	  30	  s,	  Lane	  3:	  WT	  SurA	  at	  60	  min.,	  Lane	  4:	  M2-­‐1	  SurA,	  no	  trypsin,	  Lane	  5:	  M2-­‐1	  SurA	  at	  30	  s,	  Lane	  6:	  M2-­‐1	  SurA	  at	  60	  min.,	  Lane	  7:	  M2-­‐9	  SurA,	  no	  trypsin,	  Lane	  8:	  M2-­‐9	  SurA	  at	  30	  s,	  Lane	  9:	  M2-­‐9	  SurA	  at	  60	  min.,	  Lane	  10:	  Trypsin	  without	  SurA.	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Chapter	  IV:	  Conclusions	  The	  purpose	  of	   this	   thesis	  work	  was	   to	   identify	  key	   residues	  at	   the	  C-­‐terminus	  of	  SurA	  involved	  in	  the	  chaperone	  function.	  	  The	  first	  half	  of	  the	  study	  focused	  on	  site-­‐directed	   mutagenesis	   of	   conserved	   residues	   in	   SurA.	   	   After	   many	   mutations	   that	  were	   ineffective	   at	   suppressing	   the	   function	   of	   SurA,	   one	   mutation	   was	   found,	  E(408):A,	   that	  caused	  almost	  a	  3-­‐fold	  reduction	   in	  MIC	  of	  novobiocin	  compared	  to	  wild-­‐type.	   	   Characterization	   of	   SurAE408A	   by	   CD,	   fluorescence	   emission,	   and	  fluorescence	  polarization	  revealed	  only	  slight	  changes	  in	  the	  structure	  and	  function	  when	   compared	  with	  WT	  SurA.	   	  We	  postulate	   that	   the	  difference	   in	  MIC	   could	  be	  explained	  by	  differences	  in	  the	  stability	  of	  the	  two	  proteins.	  	  Since	  an	  in-­‐depth	  study	  on	  the	  stability	  of	  these	  proteins	  was	  not	  conducted,	  we	  can	  only	  hypothesize	  that	  this	  is	  the	  case.	  	  	  
A	   small,	   intermediate	   study	   was	   conducted	   that	   centered	   around	   the	   role	   of	  aromatic	   residues	   in	  SurA.	   	  We	  generated	  16	  mutants	  of	   single,	  double,	   and	   triple	  mutations	   at	   every	   aromatic	   residue	   on	   SurA.	   	   Only	   two	   (Y125,398,422:A	   and	  Y128,398,422:A)	  were	  found	  that	  significantly	  inhibited	  SurA	  function.	  	  We	  propose	  that	   this	   is	   due	   to	   destabilization	   of	   the	   protein	   when	   the	   single	   mutations	   are	  combined.	  	  	  
The	   second	  half	   of	   this	  work	   focused	   on	   substituting	   the	   last	   10	   residues	   of	   SurA	  with	  a	  random	  peptide	  library	  of	  the	  same	  length.	  	  The	  last	  10	  residues	  are	  vital	  for	  SurA	   function	   and,	  when	   truncated,	   result	   in	   a	   non-­‐functional	   protein.	   	  We	   found	  that	  ~1.5%	  of	  all	  possible	  primary	  amino	  acid	  sequences	  will	  recover	  SurA	  function	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to	   at	   least	   50%	   of	   wild-­‐type	   activity.	   	   Twenty-­‐six	   mutants	   were	   selected	   at	   low	  concentrations	  of	  novobiocin,	  sequenced,	  and	  tested	   for	  MIC	  with	  both	  novobiocin	  and	  SDS-­‐EDTA.	  	  We	  found	  that	  there	  is	  no	  pattern	  in	  the	  sequences	  of	  mutants	  that	  recovered	   SurA	   function.	   	   The	   only	   position	   that	   showed	   any	   sequence	   homology	  among	   the	  mutants	  was	   the	   valine	   at	   position	   5	   in	   the	   10-­‐mer.	   	   The	  most	   active	  mutants	  all	  have	  either	  valine,	  or	  close	  substitutes,	  methionine	  or	  isoleucine	  at	  that	  position.	   	   However,	   it	   is	   unlikely	   that	   a	   single	  mutation	   at	   this	   position	  would	   be	  sufficient	   to	   generate	   an	   inactive	   SurA	   protein,	   because	   other	  mutants,	  which	   are	  only	  slightly	  less	  active,	  have	  other	  substitutions	  at	  that	  position.	  	  In	  conclusion,	  we	  feel	  that	  SurA	  is	  a	  very	  flexible	  protein,	  capable	  of	  accommodating	  many	  changes	  to	  its	  sequence,	  while	  still	  maintaining	  activity.	   	  Other	  proteins,	   like	  SurA,	  that	  have	  a	  wide	   range	   of	   substrates,	   might	   also	   behave	   in	   a	   similar	   way	   when	   changes	   are	  introduced	  to	  the	  primary	  sequence.	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